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ABSTRACT

EFFECT OF DNA BASE MODIFICATION ON POLYMERASE CHAIN
REACTION EFFICIENCY AND FIDELITY
by Jan A. Sikorsky
Polymerase stop assays, used to quantify DNA damage, assume single lesions are
sufficient to block thermostable DNA polymerase progression. To explore this
assumption, 90 base oligonucleotides containing normal or modified DNA bases were
amplified using real-time PCR. Data implied that the PCR efficiency was influenced to
differing degrees depending on which base lesion was present on the input
oligonucleotide; specifically, while reactions with templates containing a single 8-oxo7,8-dihydro-2’-deoxyguanosine (8-oxodG) were not noticeably altered, the presence of a
single 8-oxo-7,8-dihydro-2’-deoxyadenosine, an abasic site, or a cis-syn thymidine dimer
(TT dimer) dramatically delayed amplification. In addition, the presence of two tandem
8-oxodGs substantially hindered amplification when compared with two 8-oxodGs
separated by 13 bases which indicated that the position of lesions also influenced the
PCR. To quantify variations in amplification, novel mathematical formulae were
developed which report differences in exponential amplification as rates of damage
bypass. These treatments assume each template in the PCR is damaged to the same
degree. Quantification of damage to cellular DNA, which is a mixture of damaged and
undamaged template, required further refinement of real-time PCR mathematics;
differences in amplification were defined in terms of damage probability (lesion
frequency) rather than lesion bypass rate. The validity of these formulae was determined
using DNA samples quantified previously using current polymerase stop methods. In
addition to impacting reaction efficiency, DNA base modifications decreased reaction
fidelity. In reactions with templates containing 8-oxodGs, both the normal Watson/Crick
association with dCMP as well as the incorporation of dAMP occurred at the lesion site.
Despite similar structural characteristics, the existence of 8-oxodA resulted in a
pronounced n-1 deletion in addition to the normal association with dTMP. Sequence data
from abasic and TT dimer modifications were inconclusive but suggested the presence of
multiple nucleotide incorporation events opposite the modifications. The present work
enabled the adaptation of real-time PCR for DNA damage quantification, identified DNA
base lesions as potential PCR mutagens, and provides the basis for further refinement of
polymerase stop assays as research and clinical tools to monitor DNA damage and repair.
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CHAPTER I
1.1. Introduction
DNA in living cells can be damaged by chemical and physical processes.
Biological defenses such as the superoxide dismutase, catalase, and peroxidase enzyme
families protect against these hazardous insults (1).

DNA modifications alter base

pairing properties between complementary sequences along the length of dsDNA and can
lead to substitution mutations (2). Inherited defects, reducing the efficiency of DNA base
lesion repair, confer susceptibility to certain cancers and developmental disorders (3).
Together, these observations suggest that DNA damage is a preliminary step in
carcinogenesis. In addition, DNA base modifications may play a role in the aging
process (4). Assays for DNA damage are therefore needed for experimental monitoring
of DNA repair pathways and clinical diagnosis of DNA repair defects (5).

1.2. Purpose of the Research
The objective of this dissertation is to characterize the influences of specific DNA
base modification on Thermus aquaticus (Taq) DNA polymerase progression and fidelity
during the polymerase chain reaction (PCR) and to design methods to quantify damage to
DNA. Previous work demonstrates that aggregate amounts of DNA damage can be
detected using radiolabeling and long extension PCR protocols (5-11). The purpose of
the work presented here is 1) to determine if fluorescent detection in real-time can be
used to advance existing PCR based methods for detecting DNA damage; 2) to
experimentally validate the current assumption that all lesions block thermostable DNA
polymerase progression; 3) to characterize the mutational spectrum of defined DNA base
lesion bypass by Taq DNA polymerase; and 4) to adapt real-time PCR mathematics to
define observed changes in amplification between samples as differences in amounts of
damage to DNA.
1

1.3. Significance of the Research
Novel mathematical treatments and protocols were developed permitting the use
of real-time PCR as a method to quantify damage to synthetic and cellular DNA
templates. The real-time PCR method presented here has the potential to act as a screen
for DNA damage in a clinical setting and could be used to further diagnose late-onset
diseases that cause or are caused by accumulated damage to DNA.
In addition, as stated in Free Radicals in Biology and Medicine: “An important
question, to which little attention has been given, is the effect of DNA base damage on
the behavior of Taq DNA polymerase, especially as PCR is being increasingly used to
amplify DNA isolated from preserved or fossilized organisms (ancient DNA) (12).”
Since its advent in the mid 1980s, PCR has revolutionized clinical and basic science
research, allowing large amounts of DNA to be copied from small inputs (13). As the
limits of the PCR are pushed in disciplines such as ancient DNA study and forensic
science, where degraded and modified DNA is encountered, the need to ensure the
accuracy of collected data becomes imperative. Through the use of synthetic DNA as
PCR template, a model is provided here with which the influences of specific base
lesions on Taq polymerase fidelity can be tested. Four common DNA damage products
were found to impact nucleotide insertion and extension kinetics during the PCR.
Because of this demonstration of base modification induced PCR mutagenesis, sequence
data from damaged DNA samples should be interpreted with increased caution.

1.4. Organization of the Dissertation
Emphasis is placed on characterizing the rate of lesion bypass, the calculation of
lesion frequencies in cellular DNA, and the impact of DNA base lesions on the fidelity of
the PCR. An overview of this work, including the purpose and significance to the
scientific community, can be found in Chapter I. Relevant literature on oxidative and
ultraviolet stresses, types of DNA damage and their subsequent repair, real-time PCR
including the mathematical basis for the calculation of template abundance, and the use
of the quantitative polymerase chain reaction (QPCR) to estimate DNA damage, which
allowed the formulation of hypotheses, experiments, and subsequent conclusions
2

presented within, is described in Chapter II. Chapter III describes the development of
real-time PCR assays for the quantification of lesion bypass rate (LBR) in synthetic DNA
and the calculation of lesion frequency (LF) in cellular DNA, and a complete description
of methods used in the characterization of lesion induced mutagenesis (LIM). Chapter IV
illustrates the LBRs of four common DNA base lesions, the LIM from each, and the
validation of real-time polymerase stop assays for use in LF within ultraviolet irradiated
DNA. A summary of the work, including a discussion of the author’s conclusions drawn
from the data and their potential significance to the scientific community are presented in
chapter V. The appendices contain a complete table of oligonucleotide primer sequences
used throughout these experiments, a comparison of PCR product sizes and their impact
on SYBR Green dye incorporation and threshold cycle values, a discussion of
dissociation curve profiles of long amplicons and how different regions on a unique
template can produce multiple peaks during melt curve analysis, the derivation of
formulae to simultaneously calculate lesion frequency and lesion bypass rates, and the
author’s curriculum vitae.
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CHAPTER II
REVIEW OF THE LITERATURE
2.1. DNA Damage
‘DNA damage’ is defined by the National Library of Medicine (NLM) as drug- or
radiation-induced injuries in DNA that introduce deviations from its normal doublehelical conformation. These changes include structural distortions which interfere with
replication and transcription, as well as point mutations which disrupt base pairs and
exert damaging effects on future generations through changes in DNA sequence (14).
DNA itself is very stable; without the introduction of outside influence, the DNA
molecule undergoes minimal change (12).
DNA bases are altered by exogenous and endogenous insults. For example,
reactive oxygen species (ROS) can interact with 2’-deoxyguanosine to form 8-oxo-7,8dihydro-2’-deoxyguanosine (8-oxodG) or with 2’-deoxyadenosine to form 8-oxo-7,8dihydro-2’-deoxyadenosine (8-oxodA) (2, 15-17). Regardless of the reactive species,
repair systems are in place to prevent assault on nucleic acid and eliminate altered DNA
if damage occurs (1). These defenses are not perfect; damage products are found in most
biological systems. For example low levels of ROS-induced damage products are present
in DNA extracted from aerobic cells (12).

In vivo evidence for the removal, and

therefore the presence, of oxidative DNA damage products exists in humans, as 8-oxodG
is excreted in urine and can be used as a marker for monitoring oxidative stress and
subsequent repair within cellular DNA (3). 8-oxodG and other modified bases have
altered base pairing properties which can lead to substitution mutations (18). Defects in
DNA repair confer susceptibility to certain cancers and developmental disorders (3, 1920). In addition, due to an accumulation of DNA damage products in aging populations,
the build up of DNA damage has been implicated as a component in the aging process (4,
4

21-28). In 1956, Denham Harman proposed the free-radical theory of aging which states
that normal aging results from random deleterious damage to tissues by free radicals (2930). Since Harman’s seminal work, a large body of knowledge has accumulated which
implicates these damaging events as a unifying link between many of the theories of
aging.
The following sections provide a comprehensive review of literature pertaining to
DNA damage with an emphasis placed on work influencing the experiments presented in
subsequent chapters.

2.1.1. Oxidative stress
Oxidative stress is defined as “a disturbance in the pro- and antioxidant balance in
favor of the former, leading to potential cellular damage” (12, 31). Given that definition,
it is natural to assume that stress would be caused by either an increase in the production
of oxidants or a reduction in antioxidants. Increased oxidant production can result from
elevated O2 levels (12), the prevalence of toxins, such as those in cigarette smoke that are
metabolized to form reactive agents (free radicals) (12), or the elevated induction of
natural defenses, such as phagocytes, whose function is to generate radicals to protect
against pathogenic invasion but may ultimately lead to diseases such as rheumatoid
arthritis (12). Depletion of antioxidant defense enzymes such as copper-zinc superoxide
dismutase (CuZnSOD), manganese superoxide dismutase (MnSOD), and peroxidases by
genetic mutation or exogenous factors tip the balance in favor of oxidative stress (12). In
addition, depletion of dietary antioxidants may play a role in the increase of oxidative
stress and damage (12).

2.1.1.1. Biologically significant free radicals
In order to discuss oxidative stress, it is important to define the underlying cause
of the damage associated with elevated stress levels: the free radical. Halliwell et al.
(1999) define the ‘free radical’ in simple terms: “a free radical is any species capable of
independent existence that contains one or more unpaired electrons (12).” Although the
majority of this discussion will concentrate on oxygen-derived radical species, free
5

radicals can be generated from a wide variety of sources. Some examples of non-oxygen
derived radical species are thiyl, sulphur-centered, chlorine, carbon-centered, and
nitrogen radicals (12). In addition, many transition-metals (12), such as iron, can qualify
as free radicals under the broad definition provided above.
Radicals generated with oxygen as their center (oxygen free radicals) include
superoxide (O2*-) and the hydroxyl radical (OH*). The superoxide radical is formed when
a single electron is added to ground-state oxygen (12). The chemical formation of the
hydroxyl radical is more complicated and can be a product of numerous reactions; Fenton
chemistry, a reaction catalyzed by transition metals, and homolytic bond fission of H2O2
or H2O induced by ultraviolet or gamma radiation respectively, are two examples (12).

2.1.1.2. Endogenous production of superoxide radicals
Some biologically important reactions rely on the production of superoxide;
others generate superoxide as an unfortunate byproduct. During bacterial phagocytosis,
NADPH is oxidized producing NADP+, H+, and two O2*- molecules in an activated
enzyme complex on the plasma membrane (32). This process is triggered when a foreign
body encounters a phagocyte, becomes wrapped up in the plasma membrane, and is
engulfed into the phagocyte cytoplasm where it is in close proximity to superoxide
production. It is unlikely, given the low reactivity of O2* in aqueous solution (12), that
bacterial killing is a result of direct exposure to superoxide. Given that intra-vacuolar pH
rises in human neutrophils following bacterial phagocytosis (33), the dismutation of
superoxide to H2O2 may occur which can readily cross cell membranes and may be
converted to the highly reactive OH* (12). Certain strains of bacteria are killed by
exposure to hydrogen peroxide which may, in fact, be an underlying mechanism involved
in phagocytosis (12).
The mitochondrial electron transport chain is a large producer of O2*- in vivo. It is
estimated that, under normal conditions, as much as 3% of the total O2 reduced in the
mitochondria forms O2*- (34). This superoxide production is directly related to oxygen
concentration.

Mammalian cytochrome oxidase becomes O2 saturated at low O2

tensions, presumably at which point the prior complexes in the electron transport chain
6

stall, allowing electron leakage to occur which can then associate directly with O2
forming superoxide (34). While the overall hypothesis that superoxide is produced as a
byproduct of electron transport is generally accepted, the precise point at which this
occurs in the transport chain is hotly debated. Evidence implicates b- type cytochromes,
parts of complex I and coenzyme Q, as producers of O2*- (34). Other reports implicate
complex III (ubiquinol cytochrome c reductase) in addition to complex I (NADH
dehydrogenase) as a major source of electron transport-derived reactive oxygen species
(35).

2.1.1.3. Antioxidant defenses
In order to adapt and survive in an oxygen rich environment, aerobes have
evolved antioxidant defense mechanisms. Antioxidant defenses can be broken down into
categories such as defense enzymes (e.g. superoxide dismutases), low-molecular mass
agents (e.g. ascorbic acid), and agents that sequester potentially harmful metal ions (e.g.
iron metabolism); all having the common goal to protect against free radical formation
(36-38).

2.1.1.4. Biological consequences of free radical production
The presence of lipid peroxidation, carbonyl and amino acid modification, and
oxidative base damage products in DNA isolated from aerobic cells suggests that
antioxidant defense systems are not 100% efficient (2, 12, 15-17, 39-40). The primary
target of oxygen radical insult on a cell depends on the type of cell and the type and
amount of radical assault. For example, when H2O2 is administered to mammalian cells
grown in culture, DNA strand breakage occurs prior to any detectable lipid peroxidation
or protein modification (41-42).

This is in contrast to compounds like carbon

tetrachloride whose primary cellular target is lipid peroxidation (43-45). Regardless of
the source or target, a cell enduring oxidative stress can adapt to or be killed by radical
insult.
Adaptation can involve the up-regulation of antioxidant defense mechanisms in an
attempt to overcome the increased oxidative stress.
7

For example, E. coli can be

preconditioned to endure high levels of H2O2 (46). If E. coli cells are gradually exposed
to low levels of H2O2, they become resistant and can survive when exposed to levels that
are lethal to normal cells. Genetic adaptation can occur at the transcriptional level;
decreased transcription of cytochrome p450 results from the exposure of isolated
hepatocytes to elevated oxidative stress levels (47).
The ultimate consequence if adaptation to stress does not happen is that ATP
production in cells decreases below a critical threshold and the cells die either by
apoptosis or necrosis (12, 48). The mechanism by which a cell expires depends largely
on the type and amount of radical inducer; millimolar levels of H2O2 exposure causes
cells to swell and rupture (death by necrosis) whereas lower levels trigger the apoptotic
cascade (49).

2.1.1.4.1. Oxidative DNA damage
Reactive oxygen species can damage DNA through direct and indirect
mechanisms. The direct mechanisms by which ROS damage DNA are a primary focus,
but it is worth mentioning that ROS insults can influence DNA indirectly by such means
as interrupting enzymes responsible for DNA replication or DNA repair (2). Some
examples of direct damage to DNA by ROS are strand breakage, hydroxyl addition, and
the opening of the imidazole ring (2). Superoxide by itself, at physiologically relevant
levels, does not appear to directly react with either DNA bases or the deoxyribose sugars
(50). If, however, the hydroxyl radical is formed in close proximity to DNA, a multitude
of products result (Figure 2.1; (2, 50)). The most studied of these damage products, 8oxodG, is formed when a hydroxyl group is added to C-8 on the purine ring of guanine
(forming the C-8 OH-adduct radical) and the intermediate compound is reduced (Figure
2.2; (50)). Hydroxyl additions are not limited to guanine. If the OH* attacks adenine, it
may add to the C-8 and undergo reductions to form 8-oxodA (2). Pyrimidine bases are
also attacked by the hydroxyl radical forming additional base modifications (2).
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2.1.1.4.2. 8-oxo-7,8-dihydro-2’-deoxyguanosine
8-oxo-7,8-dihydro-2’deoxyguanine (8-oxodG; Figure 2.1A) is formed by
hydroxylating deoxyguanosine residues by direct oxidative stress (53-54), ionizing
radiation (55), and through exposure to numerous agents that indirectly elevate ROS
levels (56-57). This DNA base lesion is found at levels ranging from 10-250 molecules
per 106 guanines in some mammalian tissues (58) and is largely regarded as the most
abundant product of oxidative DNA damage (54, 59-60). In vitro studies suggest that 8oxodG is pre-mutagenic; the lesion does not absolutely block polymerase progression and
increased the likelihood of mutation during lesion bypass (18). 8-oxodG primarily exists
as a 6,8-diketo tautomer (15) which can assume either a syn or anti-orientation when
found in duplex DNA; this orientation dictates its base pairing partner (Figure 2.3; (5962)). When paired with 2’-deoxycytosine, 8-oxodG takes on the anti configuration
creating a normal Watson-Crick base pair (61-62); in the syn form, Hoogsteen pairing is
permitted and 2’-deoxyadenosine is inserted opposite the lesion creating a guanine to
thymine transversion event during the next round of DNA replication (59-60). The ratio
of dAMP/dCMP insertion is dependent on which DNA polymerase is used; with
replicative polymerases preferring dAMP while DNA repair polymerases favoring dCMP
incorporation (17). In studies testing the extension of both 8-oxodG:dA and 8-oxodG:dC
base pairs by E. coli Pol I and Pol II (both exonuclease deficient (exo-)), 8-oxodG:dA was
preferentially extended by both polymerases while 8-oxodG:dC extension was impaired
(63).

The extension of this seemingly mismatched base pair is in part due to its

geometric similarity in structure to the correct Watson-Crick A:T pair (60-62). The
situation becomes more complex in a mammalian system; the addition of proliferating
cell nuclear antigen (PCNA), a functional accessory protein in the replication complex
acting to hold the polymerase to the DNA transcript, increases the amount of extended
product beyond 8-oxodG 2.5-fold when compared with studies involving mammalian pol
δ alone (64-65).
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Figure 2.3 Base pairing of 8-oxodG. dR represents deoxyribose sugar. 2’-deoxyadenosine or 2’deoxycytosine can pair with 8-oxodG. This differential base pairing is dictated by the orientation of the
modified base relative to its deoxyribose sugar (adapted from Wang et al. (1998) (14)).

2.1.1.4.3. 8-oxo-7,8-dihydro-2’-adenosine
The adenine analog of 8-oxodG, 8-oxo-7,8-dihydro-2’-adenosine (8-oxodA), is
formed by the exposure of adenine moieties to ionizing radiation resulting in the
hydroxylation of the C-8 position through direct insult by hydroxyl radicals (Figure 2.1A;
66-67). Shibutani et al. (1993) used oligonucleotides, modified site-specifically with 8oxodA, as templates in primer extension reactions to test the insertion and extension
kinetics of DNA pol I (exo-), DNA pol α, and DNA pol β (68). While the authors do find
that singular dGMPs could bind to 8-oxodA providing the potential for mutagenesis, in
the presence of all four dNTPs at equimolar concentrations, the polymerases tested
exclusively incorporate dTMP across from the lesion (68). Taq DNA polymerase also
selectively incorporates dTMP opposite 8-oxodA (67).
More recent studies involving E. coli pol I (exo-), Taq DNA polymerase, rat DNA
pol α and pol β conflict with the Shibutani findings. While the two bacterial polymerases
still exclusively incorporated dTMP opposite 8-oxodA, mammalian polymerase α
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misinserted dGMP and pol β misinserted both dAMP and dGMP (69). The reasons for
these discrepancies in data are not known but the authors suggest that they may, in part,
be due to differences in template sequences which have been shown to impact nucleotide
insertion kinetics in studies involving other lesions (69, 70).

2.1.1.4.4. Abasic sites
Abasic sites consist of a 2’-deoxyribose moiety linked by 3’ and 5’
phosphodiester bonds to neighboring nucleotides (Figure 2.1B; (51)). These sites are
formed by hydrolyzing the glycosidic bond connecting either purine or pyrimidine bases
to the deoxyribose sugar (71). Abasic sites occur as a result of specific DNA glycosylase
removal of damaged bases or the labilization of gycosidic bonds resulting from chemical
modification of a DNA base (71). In addition, abasic sites can form as a result of
spontaneous DNA base loss (72). Abasic sites severely hinder polymerase progression
but do not completely block replication. The progression of both E. coli pol I (exo-) and
calf thymus DNA pol α polymerases is stalled at the position immediately 3’ to the
abasic site; dNMPs are subsequently incorporated with dAMP being the nucleotide
predominantly extended (51, 72). The mutational spectrum of abasic lesion bypass in
eukaryotes is more complex. During replication of plasmid vectors inserted into simian
kidney cells which contained an abasic site, dAMP, dCMP, and dTMP incorporate
opposite the lesion site with similar frequencies (74-77). In studies concentrating on the
mutational spectra of abasic lesion bypass by the recently identified Y family of DNA
polymerases (reviewed below), n-1 deletions and n+1 insertions occur in addition to the
base substitutions mentioned above (78).
Randall et al. (1987) report nearest-neighbor influences where base stacking
interactions manipulate nucleotide insertion kinetics opposite an abasic site (71). Despite
this early report, little is mentioned of these types of influences in later studies.

2.1.2. Ultraviolet radiation
The impacts of ultraviolet (UV) radiation on human health have been considered
for more than 200 years. The first documented report of “melanoma” occurred in Europe
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around the year 1800.

The incidence of melanoma is on the rise; increasing

approximately 3-7% yearly in Caucasian populations (79). Howe et al. (2001) report
that, in the United States of America, the risk of developing malignant melanoma is 1 in
90 with a mortality rate of 1 in 400 (79). Melanomas arise from abnormal transformation
of melanocytes as a result of both environmental (80-82) and genetic factors (83-84).
The most significant portion of sunlight contributing to an increase in the
propensity for certain cancers is ultraviolet radiation (85).

UV light lies in the

wavelength range of 200-400 nm and can be divided into UVA (320-400 nm), UVB
(280-320 nm), and UVC (200-280 nm) regions (85). UVC is blocked by the earth’s
ozone layer and, therefore, is assumed not to influence cancer prevalence (85). UVA is
the largest component of ultraviolet radiation to which humans are exposed; the impact of
UVA on skin cancer development is poorly documented and highly controversial (85).
Exposure to UVB wavelengths, on the other hand, is largely associated with sunburn and
an increased risk of skin cancer development. Damage associated with UVB results from
the absorption of light by nucleic acids and proteins; both of which peak in the UVB
range at 260 and 280 nm respectively (85).

2.1.2.1. Biological consequences of exposure to ultraviolet radiation
The majority of cellular responses to UV exposure stem from damage to DNA
(reviewed below). UV damage events trigger a wide array of cellular processes; most are
mediated by p53 (85). These include cell cycle arrest, DNA repair, and p53-dependent
apoptotic pathways. Due to increased levels of the pro-survival protein Bcl-2, cells may
proliferate despite excessive damage to DNA (85). If left unchecked, this aberrant
proliferation can result in the formation of malignant melanoma.

2.1.2.2. Ultraviolet DNA damage
The two major populations of DNA lesions resulting from direct UVB exposure
are cyclobutane (or pyrimidine) dimers and 6-4 photoproducts (85). 6-4 photoproducts
are formed between the 5’ sixth position and 3’ fourth position of two adjacent
pyrimidines; pyrimidine dimers are formed when bonding occurs between the number
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four and five carbon atoms on any two adjacent pyrimidines (85). Dimers are considered
to be more carcinogenic in part due to their abundance (86), an inefficiency of lesion
removal mechanisms (86), and the observation that dimers permit translesion synthesis
by certain replicative polymerases (87).
Transitions from doublet cytosines (CC) to doublet thymine (TT) bases represent
the hallmark of UVB induced mutagenesis (88-91). Cytosine to adenine and guanine to
thymine transversions, as well as DNA strand breaks, have also been documented
resulting from UVB insult (88-91). Like UVB, UVA wavelengths can mutate DNA but
in an indirect fashion. UVA radiation is absorbed by non-DNA molecules that generate
ROS (56, 92). The resulting radicals can then lead to oxidative stress induced mutation
as described above.
Cellular systems have adopted ways of combating UV induced DNA damage;
these include the reversal of damage by photolyase, the removal of lesions through
nucleotide excision repair (reviewed below), and the evolution of translesion polymerases
such as eukaryotic DNA polymerase η (pol η) whose function appears to be the bypass
of bulky lesions that stall high fidelity replicative polymerases (reviewed below; 93).

2.1.2.1.1. cis-syn Thymine-Thymine dimers
One of the major photoproducts produced when DNA is exposed to UV radiation,
the cis-syn thymine-thymine dimer (Figure 2.1C; TT dimer), results from the
cycloaddition of a 5,6-double bond between two adjacent thymine bases in DNA (52).
Pyrimidine dimers alter DNA structure; bending DNA by 7-9o and unwinding it as much
as 15o (94-96). This bending and unwinding inhibits transcription factor binding and may
perturb gene regulation (97).
The mutagenicity of TT dimers, like other UV-induced photoproducts, is
dependent upon which polymerase is responsible for replicating past the lesion. For
example, Moloney murine leukemia virus reverse transcriptase (MMLV-RT) and Vent
DNA polymerase (exo-) cannot bypass any UV DNA photoproducts, Taq DNA
polymerase inefficiently passes cis-syn dimers, and Sequenase 2.0 (exo-; U.S.
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Biochemical Corp., Cleveland, OH) is not stopped completely by any UV induced lesion
(87).

2.1.3. DNA repair mechanisms
To combat mutagenesis, organisms have evolved complex mechanisms to remove
damaged and mismatched bases. Repair mechanisms can be divided into several general
categories:

direct repair, excision repair, mismatch repair, tolerance systems, and

retrieval systems (98). Direct repair involves the reversal/removal of damage; the best
example of this is photoreactivation of pyrimidine dimers (98). Excision repair is more
complex, involving the recognition of damaged bases, excision of the DNA sequence
including the damage, and synthesis of the removed sequence effectively eliminating the
altered base (98). Mismatch repair is responsible for removing mispaired bases resulting
from incorrect base incorporation during replication, the creation of hybrid DNA during
recombination, and base conversion (98). Tolerance repair occurs when replication is
blocked at a damaged site and the system is forced to proceed by reducing polymerase
fidelity (98). Retrieval systems are a specialized version of tolerance repair which recruit
DNA recombination machinery to obtain an undamaged copy of the nucleotide sequence
from another source (98).

2.1.3.1. Base excision repair and the removal of oxidative DNA damage
Excision repair can be further sub-divided into base excision repair (BER), where
the damaged bases are the only bases to be removed, and nucleotide excision repair
(NER), where the damage is eliminated along with a number of flanking nucleotides.
NER is primarily responsible for removing bulk adducts like those resulting from UV
exposure ((1, 99); discussed below). BER, on the other hand, plays an integral part in
removing lesions resulting from oxidative stress (1, 100).
Base excision repair of oxidative DNA damage begins as damaged bases are
recognized and removed by DNA glycosylases. In order to remove the damaged base,
the N-glycoside bond between the base and sugar moiety is hydrolyzed. Next, the
apurinic/aprimidinic site is recognized and a lyase either clips the 3’ phosphodiester
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linkage (β-elimination) or both the 3’ and 5’ phosphodiester bonds (β,δ-elimination).
The resulting 3’ phosphate is cleaved leaving an exposed hydroxyl residue. Then the gap
is filled by DNA polymerase action and the remaining nick sealed by a DNA ligase
(100).
8-oxodG is the most widely studied oxidative base lesion and therefore the most
information is known about its removal by BER from DNA. First studied in E. coli, the
removal of 8-oxodG requires three integral enzymes: MutM, MutY, and MutT. MutM
functions as a glycosylase/lyase, removing the lesion from 8-oxodG/cytosine base pairs
(101). MutY is a glycosylase responsible for removing adenine from adenine/8-oxodG
mispairs (102).

Base removal results in an abasic site and the cleavage of the

phosphodiester bond (102-103). Strand synthesis is performed by DNA pol I completing
repair of the damaged base (104). MutT is a triphosphotase enzyme that cleanses the
nucleotide pool removing 8-oxodG as a substrate for DNA replication (105-107).
Homologs for each protein exist in humans and are designated hOGG1/hMMH (108109), hMYH (110), and MTH1 (111).

2.1.3.2. Nucleotide excision repair and the removal of ultraviolet DNA damage
A wide variety of bulky, DNA distorting lesions, such as those generated when
DNA is exposed to UV radiation, are repaired through NER processes. Distortions in the
double helix, brought about by the presence of these lesions, are recognized by a protein
complex (XPC-hHR23B in humans (100); UVrABC in E. coli (112)) marking the
initiation of NER. A series of proteins are recruited and an open complex formation is
adopted (100). The DNA is unwound by inherent helicase activity and the damaged site
verified in this open formation. Endonucleases cut 3’ and 5’ of the damaged site and the
damaged section of DNA is excised. A DNA polymerase synthesizes the missing genetic
information using the opposite DNA strand as a template; a DNA ligase then seals the
nick completing the ‘patch repair’ (100).
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2.1.4. Summary
The presence and removal of DNA base lesions in cellular DNA is well
established.

The accumulation of these DNA damage products increases in aging

populations; this build up of damage has been implicated as a causative component in
many cancerous phenotypes. Further rationale for these hypotheses is presented in the
following sections as modified DNA impacts replication kinetics.
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2.2. DNA Polymerases and Translesion Synthesis
Replicative DNA polymerases (replicases) are thought to maintain a high degree of
fidelity due to strict intolerance toward distortions in DNA shape (113-114). Originally
attributed solely to hydrogen bonding stringencies, observations that difluorotoluene, an
analog of thymine incapable of forming hydrogen bonds, correctly incorporates opposite
adenine during strand synthesis suggests other factors must impact nucleotide insertion
(113, 115). Differences in the melting temperatures of copolymers (ATAT), in comparison
with their respective homopolymer (AAAA or TTTT), implicates sequence specific base
stacking interactions as one such factor (113).
The Klenow fragment of E. coli DNA polymerase I was the first polymerase
structure to be determined (116). Analogous to a right hand, the polymerase has finger,
palm, and thumb sub-domains (116).

2.2.1. Polymerase processivity
Replicases are capable of polymerizing thousands of nucleotides without
dissociating from DNA (117). Two mechanisms by which different polymerase families
ensure high processivity both require the aid of additional proteins to form complexes.
Eukaryotic cellular replicases involve a sliding clamp complex (including PCNA) that
encircles DNA and tethers it to the catalytic subunit of the polymerase (118).
Bacteriophage T7 replicases have adopted a simpler method of maintaining close
association to DNA.

To become processive, T7 polymerase recruits host-encoded

thioredoxin which increases the affinity of the polymerase for the primer terminus by 80fold (117). Data suggest that thioredoxin forms a cap over the DNA groove locking the
DNA strand inside the polymerase active site and increases the processivity of the enzyme
(119).
Taq DNA polymerase and other members of the pol I family of polymerases
usually work without auxiliary processivity factors.

The X-ray structures of these

polymerases, when complexed with DNA, show that the active site of the polymerase
contains the 3’ terminus of the primer. The polymerase thumb domain folds over and acts
as a clamp, holding the DNA template strand in place. The clamping of the duplex can be
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enhanced by the tip of the thumb; a mechanism thought to control the processivity of these
enzymes (120).
2.2.2. Polymerase fidelity
Fidelity can be defined as a polymerase’s ability to insert the correct nucleotide
during DNA synthesis. As alluded to above, in addition to interstrand hydrogen bonding,
the fidelity of a polymerase is influenced by intrastrand base-stacking and interstrand crossstacking interactions (Figure 2.4; (113)). To incorporate these as factors, Goodman and
colleagues propose the ‘geometric selection’ mechanism which contends that both
geometric and electrostatic properties of the polymerase active site have profound impacts
on nucleotide insertion specificity. The authors identify three possible checkpoints for
proper geometric alignment during base insertion: initial nucleotide binding, post-binding
selection by the correct geometric shape of proper base pairing (induced-fit mechanism),
and the chemical step of phosphodiester bond formation (113, 121). Polymerases differ in
the extent at which they use each checkpoint. Sequential application of each check point
provides a high power of discrimination against the geometric abnormalities associated
with mis-matched bases (121).
For the pol I family of polymerases, the junction between the palm and finger subdomains plays a crucial role in polymerase fidelity. It is in this junction that the terminal
base pair of the primer-template association is held in a tightly constrained binding pocket.
The geometric constraint of this pocket is unsuited for mis-matched base pairs which are
detected by differences in hydrogen bonding, van der Waals’ and base-stacking interactions
(122).
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2.2.2.1. Nucleotide incorporation
Copying the genetic code requires the correct incorporation of the proper nucleotide
into the growing DNA strand. DNA polymerases recruit incoming dNTPs and mediate the
transfer of the phosphoryl group on these dNTPs to the exposed 3’ hydroxyl on the
synthesized DNA (114).

The reaction is catalyzed by a two metal ion mechanism

(normally Mg2+) where one metal ion activates the 3’ hydroxyl group on the primer,
readying it for interaction with the incoming dNTP and the other stabilizes the interaction
by negating the buildup of negative charges resulting from the departure of an oxygen
molecule (Figure 2.5; (114, 123)).
Nucleotide incorporation can be broken down into six steps: polymerase binding to
DNA, nucleotide binding, conformational change of the polymerase to a catalytically active
state, phosphodiester bond formation, pyrophosphate release, and either translocation of the
polymerase to the next residue or polymerase dissociation from DNA (93, 124-125). Using
a low fidelity polymerase (yeast polymerase η (Pol η)), Washington et al. (2001)
demonstrated that the nucleotide incorporation proceeds 150-fold faster when correct
nucleotide incorporation occurred and this insertion is dependent on an induced-fit
conformational change (126). The authors contend that the low fidelity of this polymerase
likely results by an indiscriminant induced-fit mechanism (126).
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Figure 2.5 Mechanism of nucleotide insertion. Most DNA polymerases require the presence of two
metal ions (designated Me2+) to aid in polymerization. The ions are required for both A) stabilization of
negative charges and B) the activation of 3’-OH groups, readying them to interact with incoming dNTPs
(123).

2.2.2.2. Translesion DNA synthesis
Translesion synthesis by DNA polymerases can result in the misincorporation of
nucleotides and the establishment of mutation. During normal replication, polymerization
is stalled after the incorporation of mismatched bases. This occurs due to a mis-orientation
of the 3’-hydroxyl group of the primer terminus onto which the next nucleotide is added
(123). Various DNA lesions influence DNA structure and allow stable association between
mismatched bases (18, 51, 68, 73, 94-96).

To prevent mutagenesis resulting from

polymerase replication of damaged DNA, highly specialized polymerases have evolved
that function to synthesize DNA across replication-blocking lesions (127).
Found in prokaryotes, archaea, and eukaryotes, the Y family of DNA polymerases
mediates translesion DNA synthesis (TLS).

Due to a spacious active site that can

accommodate various DNA lesions, these polymerases function to replicate damaged
DNA.

However, this loose active site decreases the fidelity of Y polymerases on

undamaged template and prevents them from being useful as replicases (127). The Y
family of translesion polymerases includes eukaryotic polymerases η, ι, κ, and Rev1, as
well as prokaryotic polymerases IV and V (127).
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2.2.2.2.1. Oxidative DNA damage mutagenesis
Most oxidative DNA adducts are not staunch replication road blocks. Bypass of
these lesions by replicases occurs resulting in base substitutions, deletions, insertions, and
frameshifting (15).

The majority of oxidative damage derived mutations are

substitutions; following a similar pattern with spontaneously generated mutation:
GC!AT transitions followed by GC!TA transversions (15).

2.2.2.2.2. cis-syn Thymine-Thymine dimer bypass
A representative example demonstrating the need for TLS is the bypass of TT
dimers by Pol η. Pol η exhibits low fidelity DNA synthesis (misincorporation frequency of
10-2 to 10-3) on undamaged template (128-129).

Using pre-kinetic steady state

experiments, Washington el al. (2003) determined that the rate limiting step for bypass of
TT dimers by Pol η, like that of undamaged template, occurs at the nucleotide
incorporation steps. The maximum rate constants for nucleotide incorporation opposite TT
dimers are nearly equivalent to those observed in experiments using undamaged template
(93). This similarity in rate constant suggests that the geometric distortions in DNA
brought on by the presence of dimers has no affect on the rate limiting step of nucleotide
incorporation and furthers the author’s contentions that Pol η bypasses thymine dimers by
retaining the entire lesion in the active site and directly incorporating adenines opposite
both thymine bases (93).
The need for TLS is further emphasized in xeroderma pigmentosum-variant (XP-V)
individuals. XP is a genetic disorder which presents a high sensitivity to UV light resulting
from deficiencies in UV lesion repair or bypass (130). XP-V is the only XP mutation not
affecting DNA repair; individuals with mutations in XP-V lack functional Pol η activity
(131). To overcome the deficiency in Pol η synthesis, Pol ζ is recruited to bypass TT
dimers leading to an increase in mutation frequency and the resulting XP phenotype (131).

2.2.3. Summary
The premutagenic impacts of DNA base modifications have been studied in both
in vitro and in vivo models using both prokaryotic and eukaryotic replication
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components. Many DNA polymerases are not absolutely blocked by DNA lesions and,
during the replication bypass of these lesions, the frequency of mutations is increased.
Given that DNA damage increases mutagenesis during replication, the need for assays to
monitor damage accumulation and repair should be clear.
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2.3. Monitoring DNA Damage and Repair
Modifications to DNA bases alter base pairing kinetics which can lead to
mutation.

Genetic defects in DNA repair pathways confer susceptibility to certain

cancers and developmental disorders. Taken together, these observations suggest that
DNA damage is a preliminary step in carcinogenesis (3, 19-20). Assays for DNA
damage are therefore needed for experimental monitoring of DNA repair pathways and
clinical diagnosis of DNA repair abnormalities (5).

2.3.1. E-beam irradiation of DNA influences quality
DNA extracted from licked envelopes exposed to electron beam irradiation differ
in both the quantity and quality of the DNA recovered when compared with nonirradiated controls (134). When typing DNA using the PCR for forensic purposes,
differential amplification between short and long amplicons may be observed and is seen
as an indicator of template quality (135-136). In complete agreement with previous
reports, DNA quality is compromised in irradiated samples; loci fail to amplify in the
order of increasing PCR target size as the extent of degradation increases (Figure 2.6;
(134)).

Non-irradiated samples exhibit balance between loci indicating less DNA

degradation (134).
In these reactions, input template amounts are standardized; the observed
decreases in amplification may be a result of damage to the target DNA in each reaction.
The observation that amplification of larger loci in irradiated samples decreases in
comparison to smaller targets from the same sample suggests that DNA damage by Ebeam irradiation is random; the probability of encountering damage increases in reactions
with larger sized PCR targets. These observations also suggest that the PCR can be used
to determine DNA quality.
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Figure 2.6. Forensic fragment analysis of DNA from electron beam irradiated envelopes. DNA from
irradiated envelopes was isolated and then amplified using Perkin Elmer AmpFℓSTR Profiler Plus® kit.
Analyzed data shows an apparent difference in the quality of DNA obtained from electron beam irradiated
envelopes; a five-fold difference in peak heights exists between the smallest (Amelogenin; G1 and G2) and
the largest (D18S51; G9 and G10) locus (adapted from 134). Numbers on the Y-axis and peak height
values represent relative fluorescent units; size of loci is given in base pairs.

2.3.2. Southern blotting
Detection by Southern analysis involves treatment of damaged DNA with lesionspecific endonucleases followed by hybridization of filter-bound restriction fragments to
a gene-specific probe (132-133). Lesion-specific digestion reduces the signal intensity of
the target gene; the frequency of lesions is proportional to the decrease in probe
hybridization (132-133). Using this method, the first observations suggesting differences
in rates of repair between transcribed and non-transcribed sequences were made (132)

2.3.3. Quantitative polymerase chain reaction
The requirement for relatively large amounts of DNA in the Southern
hybridization method led to the development of quantitative polymerase chain reaction
(QPCR) assays (5-11). These methods, referred to as polymerase stop assays, are based
on the blocking of thermostable DNA polymerase progression by lesions in DNA
template which result in a decrease in the overall rate of PCR product formation (5, 811).

Under the assumption that a single lesion is sufficient to block polymerase

progression, the QPCR method effectively measures the fraction of undamaged
templates. DNA damage results in a reduction in template amplification and can be
expressed as lesions per kilobase (10). Using this method, differences in the rates of
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DNA repair between mitochondrial (mtDNA) and nuclear DNA have been documented
(8).

2.3.4. Summary
The advent of QPCR to detect and monitor DNA damage and repair dramatically
reduced the amount of sample material needed for study and increased assay sensitivity
compared with hybridization-based damage quantification methods. These assays are
built on the assumption that thermostable DNA polymerases are blocked completely by
DNA base lesions. Experimental validation of this assumption is not readily available in
the current literature and seems improbable given the lesion bypass characteristics of
most other DNA polymerase systems. The need to explore this fundamental assumption
of QPCR resulted in the experiments presented in the following chapters.
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2.4. Modeling the Polymerase Chain Reaction in Real-Time
The polymerase chain reaction measured in real-time is becoming the standard
method for quantifying DNA and RNA (137).

These assays utilize a variety of

fluorescence based detection methods allowing high throughput, high sensitivity, and
reliable specificity (137-139).

2.4.1. Real-time PCR mathematics
Several mathematical methods are available for determining input template copy
number from real-time PCR data.

Threshold cycle ( CT ) methods determine input

template amounts by comparing the CT value from an unknown template to CT values
from templates of known copy number (Figure 2.7; (140-141)). In the standard curve
method, CT is plotted against the logarithm of copy number for a series of known input
templates and the copy number of the unknown template is determined by linear
regression (Figures 2.7B,C; (140)). When using a standard curve method, either relative
or absolute quantification can be achieved (140). The comparative threshold method
expresses relative changes in gene expression with normalization to a reference
(housekeeping) gene using the 2-∆∆ CT formula (141). The method rests on the
assumptions that the amplification efficiencies of the target and reference genes are
approximately equal and that the amplification efficiencies of both genes in exponential
phase are close to one (141).
In an alternative method developed by Liu and Saint (2002), amplification
efficiencies derived from kinetic curves are used to determine relative transcript
abundance (Figure 2.7; (142)). This method does not require equivalent amplification
efficiencies and obviates the need for standard curve construction. More recently, these
workers observed that amplification efficiencies change dynamically during simulated
PCRs and validated a mathematical method in which input template amounts are
determined from amplification curve parameters (143).
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Figure 2.7 Exponential modeling of real-time PCR. A) Polymerase chain reaction curves can be
separated into three distinct phases; geometric, linear, and plateau. Geometric phase is modeled
mathematically using a formula for exponential growth (144); the efficiency of the reaction during this
stage is constant due to all reagents being in excess quantities and the lack of reaction derived inhibitors
(144). B) Using a series of diluted standards, threshold cycle values ( CT ) are collected and C) plotted
versus the log of the input DNA concentrations; copy number of unknown templates can then be
determined using linear regression (140).

2.4.2. Real-time PCR calculations influenced by template secondary structure
Recent work by Nogva and Rudi (2004) call into question the assumption that
amplification efficiency is equal for all cycles of real-time PCR (145). Two separate
targets on the Listeria monocytogenes (LM) genome were amplified and result in an
observed copy number ratio of approximately 2:1 (145). The true ratio of target copy
numbers, previously identified through sequencing of the LM genome, is known to be 6
(145). Additional data imply that secondary structure in regions flanking PCR targets
influenced the first few cycles of amplification. This impact was undetectable at the
point in the reaction where fluorescent readings were measured (Figure 2.8; (145)).
Work such as this emphasizes the need to account for inherent template influences on the
PCR which may mask differences in subsequent mathematical comparisons.
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Figure 2.8 Early reaction cycles influence template quantification. Three types of DNA template exist
in PCRs after the third cycle; (I) input DNA, (II) PCR derived large fragments with no defined ends, and
(III) PCR derived amplicons with ends defined by the 5’ termini of both primers. Inherent differences in
template sequences, both in the target region and in the regions flanking the primer sites, alter the potential
secondary structures of the duplexed DNA and result in a rightward shift in amplification curves. This
rightward shift translates into an artificial decrease in reported copy number (adapted from Nogva and Rudi
(2004) (145)).

2.4.3. Thermus aquaticus DNA polymerase
Taq DNA polymerase, a member of the pol I family of polymerases, is widely
used as a replicative thermostable polymerase in PCRs. Under optimal conditions and
with no apparent requirement for additional auxiliary factors, Taq polymerase exhibits
moderate processivity (polymerization rate as high as 2800 nucleotides per min (146))
and fidelity (generating misincorporation events every 104 bases per cycle (147)).
Studies of Taq translesion synthesis during the PCR are limited. In the presence
of all four dNTPs, Taq is not hindered when 8-oxodA is encountered nor is mis-pairing
evident opposite the base lesion (67, 69). Slow bypass of TT dimers by Taq also occurs
(87); greater than 53% of the polymerization reactions terminated opposite the 3’-T and
between 7-15% terminated opposite the 5’-T (87).
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2.4.4. Summary
Some QPCR assays require the use of radioisotope labeled dNTPs to detect PCR
products as they are formed. By adapting real-time PCR protocols to estimate damage to
DNA, the need for hazardous isotopes would be eliminated in polymerase stop assays for
DNA damage detection. In addition, little attention has been given to the impact of
lesion bypass on the mutational spectrum of Taq DNA polymerase. Work presented here
describes the observed influences of specific DNA modifications on PCR mutagenesis.
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2.5. Summary
Cellular DNA is damaged as a result of exogenous and endogenous stimuli (12).
Repair systems are in place to prevent assault on nucleic acid (36-38) or eliminate altered
DNA if damage occurs (1, 99-100). If damage to DNA is not repaired, the extent with
which this damage influences replication of DNA is both lesion and polymerase
dependent. Bulky adducts on DNA, such as cis-syn Thymine-Thymine dimers, greatly
hinder replicative DNA polymerases. Translesion synthesis proceeds in these cases due
to the recruitment of the highly specialized Y family of DNA polymerases whose
function, to date, is lesion bypass (127). Other lesions, such as 8-oxodG, are considered
pre-mutagenic as they don’t substantially block replicative DNA polymerase progression
and, during translesion synthesis, decrease the fidelity of template replication (2). The
buildup of DNA damage increases in aging populations (21) and has been implicated as a
causative component in many late-onset diseases and cancerous phenotypes (3, 148-150).
These observations emphasize the need for assays to screen for damage in clinical
settings.
Currently, real-time PCR is becoming the standard method for measuring DNA
and RNA in a wide variety of disciplines (137). Differences in CT values translate into
differences in template abundance (141). The objective of the following body of research
is to develop a real-time PCR method to screen for DNA damage based on the
assumptions of the polymerase stop assays. The purpose of the following research is 1)
to determine if different DNA base lesions influence the rate of the PCR to different
degrees (LBR), 2) if lesion bypass occurs, characterize the influence of specific DNA
base lesions on Taq polymerase fidelity (LIM), and 3) to redefine changes in CT values
as differences in amounts of DNA damage (both LBR and LF)

By providing the

experimental and mathematical basis for using real-time PCR as a screen for DNA
damage, work toward the usage of polymerase stop assays in a clinical environment may
become possible.
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CHAPTER III
MATERIALS AND METHODS
3.1. Thermostable DNA Polymerase Lesion Bypass Rate
3.1.1. Synthesis of synthetic DNA templates
To study the lesion bypass rate (LBR) of DNA base modification by Taq DNA
polymerase, the type and amount of base lesions must be controlled. In this study,
ninety-base oligonucleotides were synthesized on an Applied Biosystems (ABI, Foster
City, CA) Model 394 DNA Synthesizer in the Marshall University DNA Core Facility
using low volume 200 nmole cycles with 30 s coupling time and standard
phosphoramidite chemistry (152-153). The sequence of the unmodified 90 base
oligonucleotide was equivalent to a portion of the human mitochondrial Hypervariable
Region

One

(Anderson

sequence

#15989-16078

(154)).

7,8-dihydro-8-oxo-

2’deoxyguanosine, 7,8-dihydro-8-oxo-2’deoxyadenosine, abasic site (tetrahydrofuran
analogue), and cis-syn thymidine dimer were introduced at specific positions as indicated
in Table 3.1 using DNA damage base cyanoethyl phosphoramidites (Glen Research,
Sterling, VA). Oligonucleotides were synthesized in the trityl-on mode and cleaved from
the polystyrene resin with ammonium hydroxide; 8-oxodG containing templates were
cleaved with ammonium hydroxide containing 0.25 M β-mercaptoethanol (18, 155).
Oligonucleotides were purified using ABI OPC cartridges (156). The OPC products
were resolved using polyacrylamide gel electrophoresis (PAGE) (Figure 4.1), and with
the RNA 6000 Nanochip assay and Agilent Bioanalyzer (Agilent Technologies, Palo
Alto, CA) to ensure the removal of synthesis failure sequences during OPC purification
(Figures 3.1, 3.2; protocol below).

Oligonucleotide templates were quantified by

measuring optical density at 260 nm, evaporated to dryness, and then stored at -80o C. A
representative subset of 90-mers (Oxo CONTROL, 8-oxodG1, and Abasic) were
analyzed by Matrix Assisted Laser Desorption Ionization coupled with a Time-Of-Flight
(Maldi-TOF) mass spectrometry (HT Laboratories, San Diego, CA) to further confirm
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oligonucleotide purity (Figure 3.3). Resulting profiles produced similar baselines and
unique peaks approximately equal to the expected molecular weights of each 90-mer
tested (Figure 3.3).
Oligonucleotide extinction coefficients were obtained using Oligo Primer
Analysis Software v5.0 (Molecular Biology Insights, Cascade, CO). One hundred µM
stock solutions of each 90-mer were prepared in low TE buffer (10 mM Tris pH 8.0; 0.1
mM EDTA) and maintained at -20o C with thawing only for analysis.
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Table 3.1. 90-mer oligonucleotides used as templates for the PCR.
a

a- The position of modification relative to the 5’ terminus of the oligonucleotide is indicated in parenthesis.
b- OxodG9 contains a base modification in the internal control region (at site 35) and was therefore only used to demonstrate decreased dye binding as it related
to increased numbers of 8-oxodG modification (Figure 4.2).

X, Y, Z, and DD represent the insertion sites of 8-oxodG, 8-oxodA, abasic, and cis-syn TT dimer modifications, respectively, into the oligonucleotide. The
dotted arrow, the solid arrow, and the dashed arrow indicate the binding sites of the forward, full-length amplicon reverse, and internal control region reverse
primers respectively (adapted from Sikorsky et al. (2004) (159)).
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TT Dimer1

Dimer CONTROL

Abasic

OxodA1

OxodG3T

OxodG3A

OxodG2T

OxodG2A

OxodG1

Oxo CONTROL

1000 bp
500 bp
200 bp

25 bp
1

2

3

4

5

6

7

8

9

10

11

12

TT Dimer1

Dimer CONTROL

Abasic

OxodA1

OxodG3T

OxodG2T

Oxo CONTROL

Figure 3.1 Purified 90-mer oligonucleotides. OPC purification of raw 90 base oligonucleotides removed
failed coupling reactions that occurred during synthesis; lanes 1 and 12 are RNA mass ladders (suggested
for ssDNA samples; Ambion, Inc., Austin, TX). As the number of 8-oxodG modifications increased,
differences in the migration patterns of the single stranded oligonucleotides were observed (OxodG3T);
these observations were also seen with PAGE (Figure 4.1) and high percentage agarose separations (data
not shown) and can be explained by an increased perturbation of backbone structure (157).

1000 bp

500 bp

200 bp

25 bp
1

2

3

4

5

6

7

8

9

Figure 3.2 Failure products from 90-mer oligonucleotide synthesis. Crude material, obtained during
purification of 90 base oligonucleotides, showed presence of truncated failure sequences; lanes 1 and 9 are
RNA mass ladders (suggested for ssDNA samples; Ambion, Inc., Austin, TX). All samples contained a 25
bp size standard to normalize for interrun variation.
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Mw: 27579.8 Da

Mw: 27584.0 Da
Oxo
CONTROL

B

OxodG1

C

Abasic

% Intensity

A

Mw: 27483.8 Da

Mass (m/z)
Figure 3.3 Maldi-TOF analyses of 90-mers. Purity of the A) Oxo CONTROL, B) OxodG1, and C)
Abasic oligonucleotides were determined by mass spectrometry; expected molecular weights were 27579.0
Da, 27595.0 Da, and 27445.9 Da respectively. No secondary peaks were observed above baseline
suggesting the presence of unique purification products; instrument resolution is approximately 1% (or
equating to 270 Da).

3.1.1.1. Resolving oligonucleotide purity using a polyacrylamide gel electrophoresis
assay
To confirm removal of synthesis failure sequences by OPC purification, the 90
base synthetic oligonucleotide templates were heat denatured at 95o C for 5 min followed
by a rapid cool to 4o C and then resolved by electrophoresis in 1x TBE on 5% denaturing
polyacrylamide at 60 watts for 1 hr. Post separation, gels were stained by immersion in
GelStar (Cambrex, East Rutherford, NJ) for 30 min and viewed on an UV
transilluminator (see Figure 4.2).

3.1.1.2. Resolving oligonucleotide purity using the Agilant 2100 Bioanalyzer and RNA
6000 Nanochip assay
To corroborate observations made from the PAGE analysis, the purified synthetic
90-mers and crude synthesis failure sequences were resolved using microchip separation
technologies. The RNA 6000 Nanochip and Agilent 2100 Bioanalyzer were prepared
according to manufacture recommended protocols. 1 µl of 100 µM crude and OPC
purified sample material was added to respective sample wells on the nanochip and
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separated using the Total Eukaryote RNA run module (suggested for ssDNA). Data was
collected by the instrument and exported as .tiff picture files (see Figures 3.1, 3.2).
3.1.1.3. Amplification of 90 base oligonucleotides by Taq DNA polymerase using realtime PCR
PCR primers were designed to amplify either the full-length 90-mer
oligonucleotide or a 45 base region with no base modifications [the internal control
region (ICR); Table 3.1; Figure 4.1; (159)] with ABI Primer Express Software v2.0. Our
standard 25 µl PCR contained 12.5 µl of ABI 2x SYBR® Green PCR Master Mix, 9.5 µl
of sterile deionized H2O, 1 µl of oligonucleotide template, 1 µl of 10 µM forward PCR
primer (5’- CCC AAA GCT AAG ATT –3’) and either 1 µl of 10 µM reverse PCR
primer (5’- TTG ATG GGT GAG TCA –3’) for full template amplification or 1 µl of 10
µM internal control primer (5’- CAT GAA AGA ACA GAG –3’) for ICR amplification.
A master mix without template was prepared based on the total number of reactions.
Oligonucleotide templates ranging from 1 amole to 100 fmoles were then added to
complete the reaction. Amplifications were performed in 96 well plates and capped with
optical grade ABI PCR strip caps. Templates were amplified under the following
conditions: 50o C for 2 min, 95o C for 10 min, then 40 cycles of 95o C for 20 s, 54o C for
30 s and 60o C for 1 min. PCR amplification and detection was carried out in an ABI
Model 7000 Sequence Detection System (SDS) according to guidelines provided (140).
CT , dissociation curve data, and delta Rn values were exported from SDS data files in

comma delimited (.csv) format.

3.1.1.4. Amplification of 90-base oligonucleotides by Restorase damage polymerase
using real-time PCR
To test if alternative PCR components impacted experimental observations, the
full-length 90-mer oligonucleotide or the ICR region were amplified using Restorase
DNA polymerase (Sigma-Aldrich, St. Louis, MO). Big band modifications to the PCR
primers were necessary to prevent degradation by Restorase’s inherent exonuclease
activity (Big Band Primers; Sigma-Genosys, Woodlands, TX). Modifications to the
Restorase amplification protocol were made to allow data collection in real-time.
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Reactions contained 1 µl of a 1:1000 dilution of SYBR Green Dye (Molecular Probes
Inc., Eugene, OR), 0.5 µl of Rox internal standard dye (Epicenter Technologies,
Madison, WI), 0.5 µl dNTP mix (Sigma-Aldrich), 2.5 µl of 10x Restorase reaction buffer
(Sigma-Aldrich), 1 µl forward primer, and either 1 µl of ICR or full-length reverse
primers; QS to 24 µl with dH2O and add 1 µl of oligonucleotide template. Complete
reactions were prepared on ice, transferred to 96 well plates, and capped with optical
grade ABI PCR strip caps. Sample plates were incubated at 4o C for 5 min to limit
exonuclease and repair activities. Plates were then transferred to an ABI 7000 sequence
detection system and amplified according to guidelines provided (140). Templates were
amplified under the following conditions: 95o C for 5 s, then 40 cycles of 95o C for 20 s,
54o C for 30 s and 60o C for 1 min and data exported as described above.

3.1.1.5. Calculation of lesion bypass rates from real-time PCR data from 90-mer
synthetic templates
Measures of lesion bypass rate, Relative Threshold Cycle and Mean Modified
Efficiency, were performed using Microsoft Excel software. Complete descriptions of
each method are found in sections 3.4.1. and 3.4.2 respectively. Inherent Template
Efficiency calculations required the fit of raw PCR data to sigmoid grow curves (section
3.4.3.); this was accomplished using SigmaPlot 2001 for Windows v7.0 (Systat Software
Inc., Point Richmond, CA). Subsequent calculations were performed using Microsoft
Excel.
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3.2. Calculation of Lesion Abundance in Cellular DNA
In order to estimate cellular DNA damage by the calculation of lesion frequency
(LF) from real-time PCR data, amplification of long targets is necessary to increase assay
sensitivity to biologically appropriate damage levels (5). To transition into long template
amplification for damage study, it was first necessary to test damage assays with long
templates containing controlled modifications.

3.2.1. Synthesis of 593-base templates with controlled modifications
Using primers designed to flank the mammalian mtDNA sequence analogous to
the Oxo CONTROL 90-mer (Anderson #15912-93 (154); Appendix A), 751 bp PCR
products were generated from total cellular DNA. PCR master mixes were created as
described in section 3.1.1.3. and amplified using the following conditions: 50o C for 2
min, 95o C for 10 min, then 40 cycles of 95o C for 30 s, 55o C for 20 s and 72o C for 1
min. These products were purified using QiaQuick PCR purification columns (Qiagen
Inc., Valencia, CA). A nested PCR was performed under the sample amplification
conditions using these purified 751 bp PCR products as templates and using the 90-mers
described above (Table 3.1) as the reverse primer and a 5’ biotin labeled primer
(FWD#12; 5’-AAG CCT GTG ATC CAT CGT GAT-3’; Sigma-Genosys, Woodlands,
TX) as the forward primer.

Crude products from eight replicate reactions were

combined, cleaned with the QiaQuick system, and concentrated in 50 µl of DNA elution
buffer. 40 µl of purified PCR product was added to 13 µl of 20X SSC and 460 µl of
dH2O to enhance the formation of dsDNA. To remove the biotin labeled anti-sense
strand, the PolyATract® mRNA Isolation System (Promega, Madison, WI) was used.
Para-magnetic particles coated with Streptavidin (SA-PMPs) were washed with 0.5X
SSC buffer and then the contents of the sample/SSC/dH2O mixture were added and
incubated at room temperature for 10 min to allow maximum streptavidin-biotin
association. The beads were then washed 4 times in 0.1X SSC; after each addition the
SA-PMPs were collected at the side of the sample tube using a specialized magnet
(Promega). One hundred µls of dH2O were added and the samples incubated at 75o C to
denature the dsPCR product and elute the anti-sense strand containing the PCR ligated
synthetic 90-mer.
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3.2.1.1. Separation of PCR products to determine homogeneity using agarose and gel
electrophoresis
To estimate specificity of amplification, crude PCR products were separated using
agarose gel electrophoresis. Unless otherwise noted, PCR products were separated in 1X
TAE buffer through 2% SeaKem ME agarose (FMC Bioproducts, Rockland MA)
containing 0.5 µg/ml of ethidium bromide at 50 to 100 V for 0.5 to 3 hrs to confirm
product size. These parameters were sufficient to resolve products ranging from 50 bp to
3 kb in length. A 123 base pair nucleic acid mass ladder was included to confirm product
size. Gels were viewed on an UV transilluminator and digital pictures taken using a Gel
Doc 2000 (BioRad Inc., Hercules, CA).

3.2.1.2. Amplification of 593 base templates for damage study
PCR master mixes were created as described in section 3.1.1.3. and amplified
using the following conditions: 50o C for 2 min, 95o C for 10 min, then 40 cycles of 95o
C for 30 s, 55o C for 20 s and 72o C for 1 min. The FWD#12 primer was used in
combination with either FWD#16138 and REV#16090 to create full-length and oligoligation internal control region (OL-ICR) amplicons (Appendix A).

3.2.1.3. Data analysis
Measures of lesion bypass rate were performed as described in section 3.1.1.5.

3.2.2. Ultraviolet irradiation of total cellular DNA
To determine if real-time PCR and changes in CT values could be used to estimate
damage in cellular DNA, the creation of samples with controlled amounts of damage to
cellular DNA was necessary. Total cellular DNA was extracted from whole blood as
described in section 3.2.2.1.

Working DNA concentrations were 5 ng per µl (as

determined by absorbance at 260 nm). One hundred µls of DNA stock solutions were
spotted on parafilm and irradiated at short range UV (254 nm) for various times using a
UVS-11 Mineralight lamp (Ultraviolet Products Inc., San Gabriel CA) fixed at a height
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of 20 mm in a sterile hood. The amount of evaporation was determined and samples QS
to 100 µl with dH2O and stored at -20o C until analysis.

3.2.3. Validation of real-time PCR for detection of biologically relevant levels of UV
damage
To validate real-time PCR as an assay for determining lesion frequency in total
cellular DNA, UV damaged DNA was acquired from Drs. Bennett Van Houten and Joel
Meyer at the National Institute of Environmental Health Sciences, Research Triangle,
NC. DNA for QPCR and real-time PCR lesion frequency calculations was prepared as
follows: MGH-U1 (bladder cancer) cells were grown as monolayers in 75 cm2 tissue
culture flasks in RPMI medium supplemented with 10% heat-inactivated fetal calf serum,
1% penicillin/streptomycin and 2 mM L-glutamine in a humidified atmosphere of 5%
CO2 in air. For the experiments, 106 cells were seeded in 10 ml medium into 10 cm
dishes and cultivated overnight at 37o C. After 24 h, the medium was aspirated, cells were
washed with PBS, and then irradiated in 3 mL PBS with 0, 10 or 20 J/m2 UV radiation,
using a germicidal Spectroline X-Series lamp (Spectroline, Westbury, NY). Cells were
harvested in 10 ml RPMI medium, centrifuged for 10 min at 1000 rpm, washed with 10
ml PBS and centrifuged again for 10 min at 1000 rpm. Cells were frozen immediately
after the exposure and stored at -80 o C to prevent DNA damage repair.
Frozen cell pellets were later thawed and immediately transferred to 2 ml lysis
buffer (Genomic-tips kit; Qiagen Inc., Valencia, CA) supplemented with 4 µl RNase A
(100 mg/ml; Qiagen) and 100 µl proteinase K (>600 mAU/ml; Qiagen). Samples were
vortexed for 5 s and incubated at 50º C for 2 h. Samples were then vortexed again for 10
s and loaded immediately onto pre-equilibrated Genomic-tip 20/G (Qiagen) columns.
Subsequent purification of genomic DNA was according to the Genomic-tips (Qiagen)
protocol. The integrity of the extracted DNA was assessed by electrophoresis through 1%
agarose gel at 30 V for 16 h.
Genomic DNA was quantitated using PicoGreen dye (Molecular Probes Inc.,
Eugene, OR) as described by Santos et al. (2002), and 15 ng of each sample was used as
template for PCR reactions (11). PCR amplifications were performed as described by
Santos et al. (2002), using primers 2372 (5’-CAT GTC ACC ACT GGA CTC TGC AC-

41

3’) and 3927 (5’-CCT GGA GTA GGA ACA AAA ATT GCT G-3’) for the polymerase
beta gene, and primers 48510 (5’-CGA GTA AGA GAC CAT TGT GGC AG-3’) and
62007 (5’-GCA CTG GCT TAG GAG TTG GAC T-3’) to amplify a non-coding region
5’ of the beta globin gene (11). PCR reaction mixtures and cycling conditions were as
described in Santos et al. (2002) except that 25 cycles of amplification were used for both
reactions (11). PCR products were quantified with PicoGreen dye and a fluorescence
plate reader, and lesion frequency was calculated by application of the Poisson
distribution (10).

3.2.2.1. Genomic DNA extraction
Total cellular DNA was extracted from whole blood using the Wizard Genomic
DNA Purification kit (Promega, Madison, WI) and protocols for extracting DNA from
blood (134). To lyse white cells, Cell Lysis Solution (Promega) was added to whole
blood; nuclear membranes were disrupted by Nuclei Lysis Solution (Promega). RNAase
was added to destroy any RNA present in the sample and Protein Precipitation Solution
(Promega) added to precipitate out any protein material. The samples were centrifuged
and the supernatant containing DNA transferred to a clean tube containing isopropanol.
White strands, indicating the presence of DNA, were visible which were then pelleted by
centrifugation. The DNA pellet was washed with 70% ethanol, the ethanol removed, and
the pellet air dried. DNA was resuspended in DNA Rehydration Solution (Promega) and
the concentrations determined by absorbance at 260 nm. Samples were aliquoted and
stored at –20o C and thawed immediately prior to experimentation.

3.2.2.2. Long extension real-time PCR
A primer walking strategy was adopted to amplify various sized fragments from
human mtDNA (Figure 3.4). Primers were adapted from Levin et al. (1999) (158), from
Ayala-Torres et al. (2000) (10), or created using ABI Primer Express Software v2.0 to
amplify sections of mtDNA; each amplicon contained the same reverse primer
(REV#14841; 5’-TTT CAT CAT GCG GAG ATG TTG GAT GG-3’). Forward primers
were designed to systematically increase amplicon size (Figure 3.4; Appendix A). A
standard 25 µl long extension PCR contained 12.5 µl of ABI 2X SYBR® Green PCR
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Master Mix, 9.5 µl of sterile deionized H2O, 1 µl of template, 1 µl of 10 µM forward
PCR primer, and 1 µl of 10 µM reverse PCR primer. Templates were amplified under
the following conditions: 50o C for 2 min, 95o C for 10 min, then 40 cycles of 94o C for 30
s and 65o C for 4 min.
Template amounts were held constant in these reactions by prior amplification of
an internal control region (LX-ICR; Figure 3.4; Appendix A) and application of a dilution
factor determined by direct cycle threshold based comparison mathematics (141). Master
mixes for the LX-ICR PCRs were constructed as described above, but reactions were
performed under the following conditions: 50o C for 2 min, 95o C for 10 min, then 30
cycles of 94o C for 15 s and 60o C for 1 min. Data was exported and calculations
performed using Microsoft Excel software.
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REV #14841

Amplicon 1 (221 bp)

Amplicon 2 (371 bp)

Amplicon 3 (693 bp)

Amplicon 4 (942 bp)

Amplicon 5 (1654 bp)

Amplicon 6 (2241 bp)

Amplicon 7 (3082 bp)

mtDNA

Figure 3.4. Amplification of mitochondrial DNA by primer walking. The schematic represents
mammalian mtDNA; reverse primer (REV #14841) was held constant and forward primers moved to
create amplicons ranging between 221 bp and 3082 bp. Actual fragment size is given in parenthesis. The
LX-ICR (
) is located within Amplicon 1 (from mtDNA #14642-#14693).

3.2.2.3. Data analysis
Measures of lesion bypass rate were performed as described in section 3.1.1.6.
Lesion frequencies were calculated from real-time PCR data using Microsoft Excel
software and equation 13 in section 3.4.4.
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3.3. Characterization of Lesion Induced Mutagenesis
3.3.1. Synthesis and amplification of modified 90-mer oligonucleotides
To determine nucleotide incorporation opposite DNA base modification during
the PCR (LIM), the amount and types of base lesions must be strictly controlled. The
generation of modified oligonucleotides (section 3.1.1.) and their respective amplification
(section 3.1.1.3.) are described above.
3.3.2. Purification of PCR product
Prior to sequencing, PCR products were electrophoresed through agarose to
confirm the presence of the correct sized amplicon (section 3.2.1.1). PCR products were
purified using the Qiagen® QiaQuick PCR amplification kit protocol (134). This protocol
is designed to purify single or double stranded DNA from PCR and other enzymatic
reactions; fragments ranging from approximately 100 bp to 10 kb are purified from
primers, nucleotides, polymerases and salts. To prevent degradation post purification,
PCR products were eluted in Buffer EB (Qiagen Inc.; 10mM Tris-Cl, pH 8.5) and stored
at -20o C until needed for further analysis.

3.3.3. Dye terminator DNA sequencing
Purified DNA products were subjected to cycle sequencing using ABI Big Dye
Terminator ready reaction kit with Taq FS polymerase (134). 2 µl of the purified PCR
product were added to 8 µl of a master-mix; master mix contained 2 µl of the ready
reaction mix (including Taq, ddNTPs, dNTPs, MgCl and buffer), 0.5 µl of a 10 µM
unidirectional sequencing primer (either forward or reverse primer from PCR reaction)
and 6.5 µl dH2O. Note: for amplicons less than 100 bp, 1 µl of the purified PCR product
was added to 9 µl of a master-mix containing 1 µl of the ready reaction mix, 0.5 µl of a
10 µM primer, and 7.5 ml dH2O. The reaction mixes were cycle sequenced using
optimized sequencing parameters (30 cycles: 95o C for 30 s, 50o C for 20 s, 60o C for 4
min; and then a terminal hold at 4o C).
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3.3.3.1. Purification of cycle sequencing product
The cycle sequencing reaction products were cleaned using a Centri-sep 100 spin
column (Princeton Separations, Princeton, NJ; (134)). Prior to use, spin columns were
hydrated with dH2O (either for 2 hrs at room temperature or overnight at 4o C) and spun
at 750 x g twice, each for 2 min (discarding the flow through between spins). Note: if
columns were soaked overnight, 30 min incubation at room temperature was necessary
before proceeding further. The entire 10 µl cycle sequencing reaction mixture was then
added to the center of the column and spun at 750 x g for 2 min. The flow through was
collected and added to 25 µl of a template suppression reagent (ABI). The samples were
denatured at 95O C for 4 min and loaded onto an Applied Biosystems 310 Genetic
Analyzer for sequence analysis.

3.3.3.2. DNA sequence analysis
Samples were processed using standard analysis parameters provided in the Seq
POP6 Rapid (1 ml) E module (Sequence Analysis software v3.3 (ABI)) and analyzed
using the CE-1 base-calling algorithm. Computer analyzed base calls were manually
edited for accuracy. Sequence comparisons were made ABI Sequence Navigator v1.0.1
software or the SeqLab Analysis platform (Accelrys, San Diego, CA).
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3.4. Mathematical Modeling of the Polymerase Chain Reaction Involving
Amplification of Multiple Templates with Differing Efficiencies1.
To explain amplification of templates with different inherent efficiencies, four
novel mathematical treatments were developed. Two of the mathematical methods, the
relative threshold cycle and mean modified efficiency, are rate-based measures of DNA
damage (measuring LBR) based on comparing data taken from the exponential phase of
amplification in reactions containing a homogenous population of DNA template; e.g.
types and amounts of damage do not vary intrasample. The inherent template efficiency
model also uses homogenous input DNA and reports results in terms of modified
template reaction efficiency (a measure of LBR) but fits raw PCR data to sigmoid growth
curves and creates comparisons based on whole PCR curve kinetics.

Damage

quantification from cellular DNA involves samples with non-homologous damage and
requires modeling proportions of damaged and undamaged template (CoLA); lesion
frequency calculations take this into consideration. The rationale for and derivation of
each is presented in the following sections.

3.4.1. Lesion bypass rate: the Relative Threshold Cycle method
The relative threshold cycle method was developed to estimate amplification
efficiency of synthetic templates containing DNA base modifications thought to impede
polymerase progression. Comparisons between data from full-length and internal control
region (ICR) reactions were based on observed threshold cycle ( CT ) values; the ICR
contained no modifications and, therefore, provides a measure of intact template amount.
Since the input template amounts in these two PCRs are equal, any increase in CT must
result from a decrease in amplification efficiency. For unmodified templates (e.g. the
ICR), if amplification is 100% efficient, the exponential formation of PCR product is

x n = 2 n x0

1

1

Novel mathematical formulae were developed in collaboration with Dr. James Denvir, Department of Microbiology,
Immunology, and Molecular Genetics, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV.
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where ( x n ) is the total fluorescence at cycle number ( n ) and ( x0 ) is the input template
fluorescence at n = 0 (140, 144). During amplification of the full-length modified
oligonucleotide, unmodified products were formed which then served as templates in
subsequent cycles. During the exponential phase of these reactions, the amount of
unmodified product ( y n ) at cycle number n is

y n = 2 y ( n −1) + EM

2

where ( E ) is the amplification efficiency of modified templates and ( M ) is the
fluorescence of modified templates.

Prior to any amplification, in reactions with

modified input template, there was no unmodified template present.

With y 0 = 0

equation 2 becomes
y n = (2 n − 1) EM

3

and the total PCR product ( z n ) at cycle n is given by
z n = ((2 n − 1) E + 1) M

4

.

In order to determine threshold cycle for the ICR and full-length PCRs, a threshold
fluorescence ( T ), fixed for all reactions was chosen, which was sufficiently larger than
the background fluorescence but small enough that the reaction was still in the
exponential phase. The cycles at which the ICR and full-length PCRs reach the threshold
level are designated CTU and CTM respectively. By substitution into equations 1 and 4,
equations that relate threshold fluorescence to cycle number for the ICR were derived;
T = 2 CTU xo

5
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and for the full-length PCR
T = ((2 CTM − 1) E + 1) M

6

.

If M = x 0 for a given template, equating equations 5 and 6 and solving for E produces:
E = (2 CTU − 1) /(2 CTM − 1) .

7

This equation can be approximated to produce the simpler equation
E ≅ 2 CTU −CTM

8

which represents the Relative Threshold Cycle (RTC) amplification efficiency. If
CTM ≥ CTU and CTM > 11 the error of this last approximation is less than 0.1%.

3.4.2. Lesion bypass rate: the Mean Modified Efficiency method

The RTC calculations require two assumptions: 1) the efficiency of the PCRs of
small DNA templates must be equal and close to 100% and 2) the input template amounts
must be held constant between reactions. To eliminate these assumptions and provide a
more precise means to quantify differences in PCRs containing damaged DNA template,
the mean modified efficiency (MME) method was created.
In general, exponential amplification of DNA template is given by
xn = (1 + E ) xn−1 , or x n = (1 + E ) n x0 ,

9

where ( x n ) is the total fluorescence at cycle ( n ), and ( E ) is the amplification efficiency.
Modified templates generate unmodified template at one efficiency and these PCR
derived unmodified templates then amplify at a different efficiency (usually higher). In
reactions containing templates with differing amplification efficiencies,
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x n = (1 + Eu ) x n−1 + E m M

10

where x n is the fluorescence of unmodified templates at cycle n, ( Eu ) is the efficiency of
unmodified templates, ( E m ) is the efficiency of modified templates, and ( M ) is the
constant fluorescence due to the modified templates. Eu is solved for separately using
equation 17 as shown in the Numerical Bootstrapping section of Materials and Methods.
There is no unmodified template at the beginning of the PCR. When x0 = 0 , equation 10
has the following solution:

xn =

[

]

Em M
(1 + Eu )n − 1
Eu

11

Since x n represents only the fluorescence due to unmodified templates, the total
fluorescence, t n , is given by

tn =

[

]

Em M
(1 + Eu )n − 1 + M .
Eu

12

Equation 12 represents a model explaining the PCR containing competing templates with
differing amplification efficiencies. In many treatments of similar analysis (for example,
(138-139, 141)), the values of x n are normalized to a control gene in order to determine
relative fold increases in PCR product. Since the aim of this method is to arrive at an
absolute measure of efficiency, M , x n , and t n here refer to background subtracted, raw
fluorescence values. For this reason, a value for M , the initial fluorescence of modified
template, must be derived (described in the Numerical bootstrapping section).
For any given set of data, the threshold cycle number CT and a given threshold
fluorescence T , equation 12 becomes
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T=

[

]

Em M
(1 + Eu )CT − 1 + M .
Eu

13

Equation 13 can then be solved for the efficiency ( E m ) of the modified templates

Em =

E u (T − M )

14

M [(1 + E u ) CT − 1]

3.4.2.1. Mean Modified Efficiency: numerical bootstrapping

In order to solve for modified efficiencies with equation 14, it was necessary to
generate values for the CT , T , M , and EU . The value of CT is directly related to an
arbitrary threshold value T and therefore determined experimentally. In order to derive
the initial fluorescence of modified template M , internal control primers were used to
amplify the unmodified ICR of the oligonucleotide templates.

Using template

concentrations that ranged over five orders of magnitude, CT values (N=5) were
collected, plotted against the base log10 of the template concentration, and the slope (m)
of the best fit line determined. The efficiency was then computed using a standard
method for amplification efficiency calculation
E = 10 − (1 / m ) − 1 .

15

The initial fluorescence value x0 for each input template could be defined using the 45
base pair reaction data and the equation

x0 =

T
.
(1 + E )CT

16

Since the same template stocks are used for both the 45-mer and 90-mer experiments, it
was appropriate to use the input fluorescent values x0 from ICR data as input measures
for 90-mer fluorescent values M .

51

The efficiency of the PCR derived unmodified templates Eu was computed in the same
manner as the internal control reaction efficiencies using equation 15.2 The efficiency of
the modified templates E m could then be determined using equation 14.

3.4.3. Lesion bypass rate: the Inherent Template Efficiency method

Despite eliminating assumptions necessary for the RTC estimation, the MME is
limited to the portion of the PCR curve where amplification is exponential and also
requires the amplification of a template at multiple input amounts. PCR kinetic data,
derived from whole curve analysis, has been used to determine input template amounts
and reaction efficiencies (141). In addition to looking at all the data points of a PCR
curve, this method can determine these variables from a single PCR.
Sigmoid growth curves can be explained by

Rn =

( Rmax )
(1 + e −( n −n1 / 2 ) /( k ) )

17

where ( Rn ) is the quantity of template at cycle ( n ), ( Rmax ) is the maximum (plateau)
value, ( n1 / 2 ) is the cycle at which Rn reaches ½ Rmax , and ( k ) is related to the efficiency
of the reaction by

E = e1 / k − 1 .

18

Equation 18 satisfies the relationship

∆ Rn

= (1 /( Rmax ))( Rn / k )( Rmax − Rn ) ,

19

so that (∆ Rn ) is proportional both to the amount of template already present, and to the
amount of potential template left for the reaction to create.
2

In theory, for the equation for our modified templates this data should no longer exactly fit a straight line. However the
deviation from a straight line is of the order of M , which is negligible.
K
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To derive a formula to incorporate the variable of having modified template
present at the onset of the reaction, an analogy to ∆ Rn above can be made, noting that the
modified and unmodified templates will create new templates but with different
efficiencies. To this end, let Rnu represent the amount of unmodified template in the
reaction after n cycles and X o represent the amount of modified template present (a
constant). The rate of change of Rn is assumed proportional to ( xo / a ) + ( Rn / b) , and the
amount of template the reaction is still able to create equates to ( Rmax − Rn ) . That gives

∆ Rn

= (1 /( Rmax ))(( xo / a) + ( Rn / b))( Rmax − Rn )

20

where ( a ) and ( b ) are interpreted by

E m = e1 / a − 1

21

and

Eu = e1 / b − 1 ;

22

E m is the efficiency of the modified template and Eu is the efficiency of the unmodified

template. Equation 20 has the solution:

Rn + x o =

xo + Rmax (1 − e − n ((1+bxo ) /( abRmax )) )
(1 + (aRmax ) /(bxo ))e −n (( a +bxo ) /( abRmax )

23

representing the Inherent Template Efficiency (ITE) where ( Rn + xo ) is the total template
in the reaction.
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3.4.4. Calculation of lesion abundance: determination of Lesion Frequency using CT
values

Equations 8, 14, and 23 (RTC, MME, and ITE respectively) represent measures of
reaction rate for modified DNA template. These formulae assume that no unmodified
templates are present at the beginning of each PCR. Therefore, strictly speaking, they do
not represent meaningful measures of damage in cellular DNA due to the likelihood that
cellular DNA would be a mixture of modified and unmodified template.

For the

successful adaptation of real-time PCR as a polymerase stop based assay for biologically
significant DNA damage quantification, changes in CT values must be redefined as
lesion frequency, rather than reaction rate.
For polymerase chain reaction with efficiency (E), the number of target DNA
molecules (xn) after (n) cycles of the reaction is given by
xn = (1 + E ) n x0 ,

(144)

24

where x0 denotes the number of input DNA molecules.
In this assay, undamaged (control) DNA are amplified and compared to the amplification
of damaged DNA. The aim is to estimate the proportion (p) of damaged bases in the
DNA from the treated sample material. Previous work suggests the major DNA lesion
created by UV radiation effectively blocks the PCR (151); the assumption that cellular
DNA containing one or more damaged bases in the target region does not contribute to
the reaction can therefore be made. Denoting the length of the target DNA molecule by
N, the probability that an input molecule is undamaged over the whole length of the target

is (1-p)N. Thus the number of input molecules contributing to the reaction is (1-p)N x0.
Thus, for damaged DNA with lesion frequency (p) the reaction is modeled by the
equation
xn = (1 + E ) n (1 − p ) N x0 .

25

A threshold value (T) common to both the reaction for damaged and undamaged
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templates was chosen, and input templates held constant as described above. The
fractional cycle number at which the reaction reached the threshold was measured. For
the reaction with undamaged DNA this threshold cycle is denoted as CU; for damaged
DNA this threshold cycle is CD. Applying equations (1) and (2) with xn=T, produced
T = (1 + E ) CU x0 , and
T = (1 + E ) CD (1 − p ) N x0 .

Equating these two expressions for T gives
(1 + E ) CU x0 = (1 + E ) CD (1 − p ) N x0 , and so
(1 + E ) CU −CD = (1 − p ) N .

Denoting CU – CD = ∆CT, produced
(1 + E ) ∆CT / N = 1 − p , or

p = 1 − (1 + E ) ∆CT / N .

26

It is important to note: theoretically, these two methods, the rate of lesion bypass
(RTC, MME, and ITE) and the proportion of damaged bases at the beginning of the PCR
(lesion frequency) can be used in combination to produce a more accurate measure of
DNA damage. In addition, by amplifying two target lengths, both LBR and LF can be
determined using more advanced formulae (Appendix E).
instrument precision prevent this from being possible.
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Currently, limitations in

CHAPTER IV
Results
4.1. Quantification of DNA Damage
4.1.1. Modified oligonucleotides as templates for the PCR

To characterize the influence of defined lesions, both in terms of LBR and LIM,
on the PCR, a series of 90-base oligonucleotides containing 8-oxodG, 8-oxodA, abasic
site, or TT Dimer modifications were synthesized for amplification by the PCR (Table.
3.1, Figure 4.1A). These modifications were selected because they are prevalent products
of damage induced by oxidation and irradiation (15).

To ensure oligonucleotide

homogeneity, synthesis products were analyzed by nanochip electrophoresis (Figure 3.2),
Maldi-TOF (Figure 3.3), PAGE (Figure 4.2), and high percentage agarose gel
electrophoresis (data not shown) separation techniques.

In all gel based separation

methods, an apparent decrease in oligonucleotide fluorescence correlated with increased
numbers of inserted 8-oxodG bases (Figures 3.2, 4.2).

A
REVERSE PRIMER

B

FORWARD PRIMER

INTERNAL CONTROL PRIMER

Figure 4.1. Model of oligonucleotide amplification. A) Amplification of the full-length oligonucleotides
differing only in the type and number of modified bases. Any difference observed during amplification can
be attributed to the incorporated modified bases and their influence on the PCR. B) Amplification of the
internal control region (ICR); this ICR contains no modification and therefore amplifies with the same
efficiency in each template providing the ability to quantify input template amounts and normalize
concentrations in subsequent calculations. * represents sites of modified DNA bases.
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Oxo
OxodG2T OxodG4T
CONTROL

OxodG6

OxodG9

Figure 4.2. Polyacrylamide gel electrophoresis of 90-mer oligonucleotides. Oligonucleotides which
contained increasing amounts of 8-oxodG modifications presented decreased staining intensities; each lane
contained 20 pmol of oligonucleotide; each oligonucleotide was run in duplicate. Complete sequences of
oligonucleotides are found in Table 3.1.

The decrease in dye binding as the number of tandem 8-oxodGs increases can be partially
explained by a decrease in stable secondary structure. During cycle sequencing reactions
containing no sequencing primer, Oxo CONTROL and OxodG2T oligonucleotides folded
back upon themselves and auto-sequenced (Figures 4.3B and 4.3C respectively). This
suggested that stable structures could form in the 90-mers at cycle sequencing extension
temperatures.

Auto-sequencing was perturbed as the number of tandem 8-oxodGs

increased (OxodG4T and OxodG6; Figures 4.3D and 4.3E, respectively). This disruption
of secondary structure would in turn result in decreased dye intercalation.
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A
B

C

D

E

Figure 4.3. Auto-sequencing of 90-mer oligonucleotides. Black, green, red, and blue represent guanine,
adenine, thymine, and cytosine bases respectively. A) The schematic represents a potential hairpin at the 3’
end of the oligonucleotides. The potential sites of 8-oxodG modification are boxed in red; the underscored
area represents total readable sequence in auto-sequencing reactions. 90-mer oligonucleotides, B) Oxo
CONTROL, C) OxodG2T, D) OxodG4T, and E) OxodG6, were subjected to cycle sequencing as described
in the materials and methods but without a sequencing primer. During these reactions, auto-sequencing
occurred originating at the 3’ end of the 90-mers (B,C) which was eliminated by the addition of multiple
tandem 8-oxodG modifications (D,E).

Since oligonucleotides are synthesized in the 3’ to 5’ direction; an internal primer was
developed to amplify a 45 base control region (ICR) on the 5’ end of the oligonucleotides
and confirm the synthesis of full-length template (Figure 4.1B). Positive amplification of
this region indicated the presence of intact oligonucleotide. The benefits of this
oligonucleotide model include the ability to control the amount, positioning, and
specificity of DNA base modification during synthesis, as well as the elimination of any
PCR inhibitors possibly present in cellular DNA.

Oligonucleotide templates were

amplified and PCR products compared after separation by agarose gel electrophoresis
(Figure 4.4). After 40-cycles in the PCR, all oligonucleotides produced both full-length
and ICR products; approximately 90 and 45 bps, respectively. This implied that the
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templates were full-length and that the DNA modifications did not completely block
polymerase progression as suggested previously (5).
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OxodG3A
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OxodG3T
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OxodG6

OxodG4T

9

10

11

12

13

14

15

16

17

123 bp

OxodA1

Dimer
CONTROL

Abasic

TT Dimer1

Figure 4.4. Product gels from PCRs with 90-mer oligonucleotides templates. Products obtained from
full-length (
) and ICR (
) reactions were electrophoresed through agarose in duplicate; sizes
were approximately 90 and 45 base pairs respectively. Lane 1 is a 123 base DNA mass ladder; lanes 2-3,
6-7, 10-11, and 14-15 are full-length amplicons; lanes 4-5, 8-9, 12-13, and 16-17 are ICR amplicons.

4.1.1.1. Increasing the number of tandem 8-oxodG alters product formation.

To determine if tandem 8-oxodG modifications changed the amplification rate in
the PCRs, a subset of oligonucleotides were amplified for 25 cycles (Figure 4.5). While
the band intensities from the full-length Oxo CONTROL reactions mimicked those of the
Oxo CONTROL ICR PCRs, bands from the full-length reaction products of OxodG2T
decreased and those from the OxodG4T and OxodG6 were not detected. The presence of
ICR PCR products from OxodG2T, OxodG4T, and OxodG6 indicated the apparent
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decrease in full-length products was not due to lack of available oligonucleotide template.
The observed differences in full-length product formation at cycle 25 versus cycle 40
from PCRs containing templates with tandem 8-oxodG modifications (e.g. OxodG4T;
Figures 4.4, 4.5) signified that the plateau phase of the reaction was delayed as a result of
tandem 8-oxodG base modifications.

1

2

3

4

Oxo
CONTROL

5

6

7

8

9

OxodG2T

10

11

12

OxodG4T

13

14

15

16

OxodG6

Figure 4.5. Product formation is delayed in PCRs with tandem 8-oxodGs. PCRs were stopped after 25
cycles; products were obtained from full-length (
) and ICR (
) reactions and electrophoresed
through agarose in duplicate. Sizes were approximately 90 and 45 base pairs respectively. Lane 1 is a 123
base DNA mass ladder; lanes 2, 5-6, 9-10, and 13-14 are full-length products; Lanes 3-4, 7-8, 11-12, and
15-16 are ICR products. PCR products from full-length Oxo CONTROL reactions were unaffected by
shortened cycling numbers, where as products from OxodG2T reactions decreased; full-length products
from OxodG4 and OxodG6 were not detected. ICR reactions produced products from each template that
mimicked 40 cycle results (Figure 4.4).

4.1.1.2. Base modifications perturb amplification efficiency to different degrees

To further investigate band differences between 25 and 40 cycle PCR data, the
ABI 7000 Sequence Detection System was used to amplify both the full-length and ICRs
from the 90-mer oligonucleotides (Figures 4.6-4.8).

ICR amplification curves from

reactions containing the Oxo and Dimer CONTROLs were equivalent to amplification
curves from their respective full-length reactions (Figures 4.6, 4.8). This indicated that,
devoid of any base modification, both amplification targets react similarly during the
PCR.

ICR curves from each template, when compared with one another, were

superimposable demonstrating that template amounts were equal and that the ICR
amplified with the same efficiency in each template (data not shown). While the fulllength amplification curves from the controls mimicked the ICR curves, there were
substantial right-shifts in the OxodA1, OxodG3A, OxodG2T, OxodG3T, OxodG4T,
OxodG6, and Abasic amplification curves (Figure 4.7). A right-shift was also observed
in the amplification of the full-length TT dimer template (Figure 4.8).
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Delta Rn

10

1

1

0

Cycle Number
Figure 4.6. Amplification of unmodified Oxo CONTROL oligonucleotide in real-time. Oxo CONTROL
templates containing no base modification were amplified (1fmole; N=5) using primers targeted for the 45 bp
(
) ICR and the (
) full-length oligonucleotide (85 bp PCR product). Delta Rn is the baseline
subtracted PCR product fluorescence normalized to an internal dye (ROX).
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1
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0

10

1

1

0

10

1

1

0

Cycle Number
Figure 4.7. Amplification of oligonucleotides containing modified bases. Nine oligonucleotides containing
varying types and amounts of base modification were amplified (1fmole; N=5) using primers targeted for the
(
) ICR and the (
) full-length oligonucleotide (85 bp PCR product). Delta Rn is the baseline
subtracted PCR product fluorescence normalized to an internal dye (ROX). A rightward shift in amplification
profiles increased as the amount of modification to the oligonucleotide increased. In addition, shifts in
amplification profiles varied depending on the specificity of base modification on the input template. Once
Taq DNA polymerase bypassed the site of modification, a full-length PCR derived unmodified amplicon was
created and resulted in curve shapes that mimicked the unmodified Oxo CONTROL (Figure 4.6). All data
sets span cycles 1 through 40.
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Delta Rn

Cycle Number
Figure 4.8. Amplification of oligonucleotides containing a cis-syn thymidine dimer modification.
Oligonucleotides containing a cis-syn thymidine dimer were amplified (1fmole; N=5) using primers targeted
for the (
) ICR and the (
) full-length oligonucleotide (85 bp PCR product). Delta Rn is the
baseline subtracted PCR product fluorescence normalized to an internal dye (ROX). A rightward shift in
amplification profiles occurred in reactions with modified template that was not observed in the Dimer
CONTROL.

Amplification of the ICRs (Figures 4.6-4.8) provides a measure of oligonucleotide
quantity and quality.

Relative input template amounts were calculated using an

adaptation of the 2−∆∆CT based method described by Livak et al. (2001) (2−∆CT; Tables
4.1, 4.2; (141)).
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Table 4.1. Relative input template amounts from ICR amplification data.

Sample
Oxo CONTROL
OxodG1
OxodG2A
OxodG2T
OxodG3A
OxodG3T
OxodG4T
OxodG6
OxodA1
Abasic
Dimer CONTROL
TT Dimer1

Mean CTa
10.1
9.57
9.47
10.0
9.91
13.0
10.1
10.2
10.5
10.0
10.3
10.1

S. D. CTb
0.22
0.31
0.37
0.11
0.17
0.34
0.05
0.06
0.06
0.03
0.35
0.09

2-∆CT
1.00
1.47
1.57
1.05
1.15
0.14
1.05
0.94
0.76
1.06
0.88
1.04

Relative
Changec
0.0%
46.6%
56.9%
4.5%
15.4%
-86.5%
4.9%
-6.4%
-23.6%
6.0%
-12.4%
4.4%

a- Mean CT values were calculated by averaging five amplifications of the ICR target, each containing 1
fmole of input DNA, at a threshold (T) of 1.0.
b- S. D. CT is the standard deviation of the threshold hold cycle values used to compute Mean CT .
c- Relative change determined by comparison to Oxo CONTROL data.

In data taken from ICR reactions, relative changes in input template amounts ranged from
an 86% decrease (OxodG3T) to a relative increase of 57% (OxodG2A), with the majority
of input template amounts differing by less than 25%; when compared with Oxo
CONTROL amplification results (Table 4.1). This indicated that most oligonucleotide
concentrations were equivalent to that of the Oxo CONTROL. Data from full-length
reactions provided a much wider range of variation; from a 99.9% decrease (OxodG6) to
an 86% increase (Dimer CONTROL) in copy number with the majority of input template
amounts differing by greater than 80% when compared with the Oxo CONTROL (Table
4.2).
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Table 4.2. Relative input template amounts from 90-mer amplification dataa.

Sample
Oxo CONTROL
OxodG1
OxodG2A
OxodG2T
OxodG3A
OxodG3T
OxodG4T
OxodG6
OxodA1
Abasic
Dimer CONTROL
TT Dimer1
a- Calculated as described in Table 4.1.

Mean CT
11.0
11.1
11.1
17.1
15.8
21.4
18.4
21.5
13.6
17.1
10.1
17.3

S. D. CT
0.26
0.35
0.05
0.09
0.09
0.25
0.04
0.08
0.07
0.04
0.21
0.12

2-∆CT
1.00
0.937
0.916
0.014
0.036
0.001
0.006
0.001
0.162
0.014
1.86
0.013

Relative
Change
0.0%
-6.3%
-8.4%
-98.6%
-96.4%
-99.9%
-99.4%
-99.9%
-83.8%
-98.6%
86.3%
-98.7%

The formula used to calculate input template amounts in these tables assumes
constant and equivalent reaction efficiency during exponential phase (141). Therefore,
when using 2−∆CT based mathematics, any difference in CT values is reported as a
difference in input template amount (141). Given the large discrepancies in apparent
input template amount between the two sets of data (Tables 4.1, 4.2) and that reactions
differed only by the presence of DNA base modification on the full-length target
template, a conclusion that DNA modifications influenced the number of cycles needed
to reach threshold fluorescence could be drawn.
Since the ICR in each oligonucleotide contains no DNA modification, template
amounts calculated from ICR data are a correct representation of input template quantity.
Therefore, the observed right-shifting of the amplification curves (Figures 4.6-4.8) in the
full-length reactions (OxodA1, Abasic, TT Dimer1, and various templates with tandem
OxodGs) must result from substantially reduced amplification efficiencies.

4.1.1.3. Lesion bypass rate: estimation of RTC efficiency for unmodified and modified
templates

The relative threshold cycle (RTC) method was developed to quantify differences
in the rates of amplification of modified templates (151). The RTC method compares CT
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data from the ICR ( CTU ) and full-length ( CTM ) reactions and reports results as changes
in amplification efficiency. CTU and CTM were determined at six template amounts (1
amole to 100 fmole) for each oligonucleotide and the respective RTC efficiencies for
each calculated using equation 8 (Tables 4.3-4.5).

In early real-time PCR cycles,

replication of the full-length modified oligonucleotide gave rise to unmodified PCR
products which were exponentially amplified in subsequent cycles. Even though the
amplification curves of unmodified and some modified templates had similar exponential
phases, a rightward shift in the curves of templates with single 8-oxodA, abasic site, or
TT dimer modifications and amplification curves of template with three non-adjacent or
two-plus tandem 8-oxodGs were observed (Figures 4.6-4.8). These shifts stemmed from
prolonged lag phases that could be described as a difference in CT values and which then
translated into RTC efficiencies.
The average RTC efficiency of the Oxo CONTROL was 0.544. The observation
that Oxo CONTROL template RTC efficiency was less than 1.0 suggests that the inherent
efficiency of the ICR was higher than that of the full-length template reaction. In order to
prepare an appropriate control template for the TT dimer template, several thymidine
substitutions in the Oxo CONTROL template were made (Table 3.1). It is interesting to
note that the RTC efficiency from this Dimer CONTROL (1.03) was greater than that of
Oxo CONTROL (0.544; Tables 4.3, 4.5). This difference could be explained by a
reduction in the stability of secondary structure in the Dimer CONTROL template at PCR
extension temperatures (Figures 4.9, 4.10), brought on by the aforementioned sequence
change and resulted in improved Taq progression. These observations emphasize a need
for matched template controls in the RTC and other direct CT comparison methods.
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Figure 4.9. Predicted secondary structures of 90-mer Oxo CONTROL oligonucleotide sequence. The
Oxo CONTROL oligonucleotide sequence was found to form 13 stable secondary structures at the PCR
extension temperature (60o C). Structures are presented in order of decreasing stability; with the top-left being
the most stable; energies ranged from -2.4 to -0.4 kcal/mole. Secondary structure predictions were computed
using m-fold software (SeqLab Accelrys, San Diego, CA).

Figure 4.10. Predicted secondary structures of 90-mer Dimer CONTROL oligonucleotide sequence.
The Dimer CONTROL oligonucleotide sequence was found to form 2 stable secondary structures at the PCR
extension temperature (60o C). Structures are presented in order of decreasing stability; with the top-left being
the most stable; energies were -0.7 and -0.1 kcal/mole respectively. Secondary structure predictions were
computed using m-fold software (SeqLab Accelrys, San Diego, CA).

While the RTC efficiency of the Oxo CONTROL and OxodG1 templates showed
no statistically significant difference (p = 0.05), the mean RTC efficiencies of the
OxodA1 and Abasic were 0.114 and 0.009 which represented decreases of 81.2% and
98.5% respectively when compared to the Oxo CONTROL template (significantly
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different at p < 0.001 in both cases; Table 4.3). The mean RTC efficiency from the TT
Dimer1 template was 0.0079 which, when compared to the Dimer CONTROL template,
represented a 99.2% decrease in RTC efficiency (significantly different at p < 0.001;
Table 4.5). These observations, taken together, implied that different lesions on input
DNA template altered amplification to differing degrees.
The amount and position of 8-oxodG modifications relative to one another
influenced the PCR (Tables 4.3, 4.4).

As the number of non-adjacent 8-oxodG

modifications was increased (OxodG1, OxodG2A, and OxodG3A), the observed mean
RTC efficiencies decreased (0.407, 0.313, and 0.018 respectively). When compared with
the Oxo CONTROL, OxodG3A RTCs were reduced by 97% (statistically significant at
p < 0.001). While the presence of two 8-oxodG modifications separated by 13 bases
(OxodG2A) had no statistically significant impact on RTC efficiency, the mean RTC
efficiency from reactions containing templates with two adjacent 8-oxodGs (OxodG2T)
was 0.0214. This represented a 96% decrease in comparison to the Oxo CONTROL
(significantly different at p < 0.001). The further addition of adjacent 8-oxodG
modifications continued to impact RTC efficiency; decreasing RTC to 0.0035 for
OxodG3T reactions (a 99% reduction; Table 4.4). Taken together, these data suggested
that the progression of Taq polymerase was influenced by the number of and strongly
impeded by the juxtaposition of 8-oxodG bases.
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Table 4.3. RTC amplification efficiencies of templates with non-adjacent lesions.
Input
Template
Oxo CONTROL

OxodG1

OxodG2A

OxodG3A

OxodA1

Abasic

Mean
CTUa

Mean
CTMa

∆CT
(U-M)

RTCb

Mean
RTC

S.D.

C.V.c

0.544

0.175

0.32

0.407

0.123

0.30

0.281

0.150

0.53

0.0185

0.00840

0.45

0.114

0.0222

0.20

0.0090

0.00310

0.35

100fmole

3.93

4.16

-0.233

0.851

10fmole

6.49

7.17

-0.679

0.625

1fmole

10.1

11.0

-0.874

0.546

100amole

13.4

14.5

-1.14

0.455

10amole

16.4

17.8

-1.34

0.396

1amole

19.9

21.2

-1.36

0.391

100fmole

3.41

4.32

-0.910

0.532

10fmole

5.97

6.81

-0.843

0.557

1fmole

9.57

11.1

-1.52

0.349

100amole

12.9

15.0

-2.05

0.241

10amole

16.1

17.3

-1.20

0.434

1amole

19.5

21.1

-1.60

0.330

100fmole

3.46

4.83

-1.37

0.388

10fmole

6.22

7.26

-1.04

0.488

1fmole

9.47

11.1

-1.65

0.319

100amole

12.6

14.5

-1.90

0.267

10amole

15.9

19.2

-3.24

0.106

1amole

19.4

22.5

-3.08

0.119

100fmole

4.34

9.19

-4.86

0.0345

10fmole

6.74

12.4

-5.62

0.0204

1fmole

9.91

15.8

-5.86

0.0172

100amole

13.2

19.3

-6.14

0.0142

10amole

16.4

22.8

-6.43

0.0116

1amole

19.5

25.7

-6.24

0.0133

100fmole

4.80

7.65

-2.85

0.139

10fmole

7.30

10.2

-2.87

0.137

1fmole

10.5

13.6

-3.11

0.116

100amole

13.8

16.9

-3.11

0.116

10amole

17.2

20.7

-3.45

0.0914

1amole

20.4

24.0

-3.55

0.0852

100fmole

4.37

10.4

-6.06

0.015

10fmole

6.90

13.6

-6.71

0.0096

1fmole

10.0

17.1

-7.11

0.0073

100amole

13.5

20.6

-7.11

0.0072

10amole

16.8

23.9

-7.12

0.0072

1amole

20.2

27.2

-7.07

0.0075

a- Mean CTU and CTM values were calculated by averaging five amplifications of the ICR and fulllength targets at a threshold (T) of 1.0.
b- RTC efficiencies were derived using equation 8 (151).
c- C.V. is the coefficient of variation calculated by dividing the standard deviation of the RTC by the mean
RTC.
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Table 4.4. RTC amplification efficiencies of templates with adjacent lesionsa.
Oxo CONTROLb

OxodG2T

OxodG3T

OxodG4T

OxodG6

Input
Template

Mean
CTU

Mean
CTM

∆CT
(U-M)

RTC

Mean
RTC

S.D.

C.V.

100fmole

3.93

4.16

-0.233

0.851

0.544

0.175

0.32

10fmole

6.49

7.17

-0.679

0.625

1fmole

10.1

11.0

-0.874

0.546

100amole

13.4

14.5

-1.14

0.455

10amole

16.4

17.8

-1.34

0.396

1amole

19.9

21.2

-1.36

0.391
0.0096

0.0032

0.34

0.0035

0.0009

0.26

0.0038

0.0010

0.25

0.0005

0.0002

0.32

100fmole

4.07

10.1

-6.01

0.0156

10fmole

6.83

13.6

-6.74

0.00940

1fmole

10.1

17.1

-7.08

0.00740

100amole

13.5

20.6

-6.95

0.00809

10amole

16.6

23.8

-7.21

0.00670

1amole

19.7

26.3

-6.62

0.0102

100fmole

6.50

14.4

-7.93

0.0041

10fmole

9.34

17.7

-8.32

0.0031

1fmole

13.0

21.4

-8.38

0.0030

100amole

16.1

24.7

-8.57

0.0026

10amole

19.4

27.6

-8.28

0.0032

1amole

22.5

30.1

-7.60

0.0052

100fmole

4.01

11.8

-7.78

0.0046

10fmole

7.08

15.2

-8.12

0.0036

1fmole

10.1

18.4

-8.37

0.0030

100amole

13.6

21.9

-8.26

0.0033

10amole

16.9

25.2

-8.33

0.0031

1amole

20.2

27.7

-7.53

0.0054

100fmole

4.17

14.8

-10.7

0.0006

10fmole

7.19

18.1

-10.9

0.0005

1fmole

10.2

21.5

-11.3

0.0004

100amole

13.8

24.8

-11.1

0.0005

10amole

17.0

28.2

-11.3

0.0004

1amole

20.1

30.3

-10.2

0.0009

a- CTU , CTM , RTC, and C.V. were calculated as described in Table 4.3.
b- Data taken from Table 4.3.
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Table 4.5. RTC amplification efficiencies of templates with cis-syn TT dimersa.
Input
Template

Mean
CTU

Mean
CTM

∆CT
(U-M)

RTC

Mean
RTC

S.D.

C.V.

1.03

0.195

0.19

0.0079

0.0025

0.32

Dimer CONTROL
100fmole

4.21

4.11

0.096

1.07

10fmole

6.94

6.62

0.319

1.25

1fmole

10.3

10.1

0.215

1.16

100amole

13.5

13.4

0.124

1.09

10amole

16.6

16.7

-0.071

0.952

1amole

19.6

20.1

-0.534

0.690

100fmole

4.31

10.7

-6.42

0.0117

10fmole

7.03

13.7

-6.71

0.0096

1fmole

10.1

17.3

-7.20

0.0068

100amole

13.4

20.4

-6.95

0.0081

10amole

16.6

23.8

-7.24

0.0066

1amole

19.3

27.0

-7.77

0.0046

TT Dimer1

a- CTU ,

CTM , RTC, and C.V. were calculated as described in Table 4.3.

The RTC method normalized the observed CT value for each full-length PCR to
the ICR PCR CT value in calculating amplification efficiency. In deriving the RTC
formula, the assumption was made that the ICR amplification efficiency was 100%
because this region contained no base modifications. RTC efficiencies were calculated
for unmodified templates based on simulated ICR efficiencies in the 80 to 100% range;
no significant effect on RTC efficiencies was observed (data not shown). More refined
mathematical models (140, 142, 160-165) may be needed to detect subtle differences
between the amplification efficiencies of undamaged templates and templates containing
modifications that have subtle influences on Taq polymerase progression.

4.1.1.4. Lesion bypass rate: calculation of MME for unmodified and modified
templates

The mean modified efficiency method builds on the RTC method for quantifying
aggregate damage to DNA template using real-time PCR. These mathematical formulae
were designed to help explain differences observed in PCR curves from synthetic
templates that contained DNA base lesions while holding input template quantity
constant. It is evident, based on previous observations, that lesions perturb amplification
to different degrees and that unmodified amplicons are created during cycling that
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mimicked the reaction efficiencies of the control templates. The RTC method assumes
that the reaction efficiencies from the ICR and full-length amplifications are identical and
that these are interchangeable between templates (151). RTC efficiency can characterize
large differences resulting from lesion bypass (Tables 4.3-4.5). When using this method
to estimate DNA damage, no significant difference was measured between the Oxo
CONTROL, OxodG1, and OxodG2A reactions.

In order to further characterize slight

differences between PCRs of modified templates not distinguishable using RTC, the
reaction efficiencies for the ICR and full-length amplifications, as well as the amount of
fluorescence generated by each input template (corresponding to input template
amounts), were determined and incorporated into the equation for MME (equation 14).
Calculated ICR reaction efficiencies ( E ICR ) from oligonucleotide templates
ranged from 0.946 to 1.056 (Table 4.6). The reaction efficiencies for the full-length
amplicons ( Eu ) ranged from 0.922 to 0.991 (Table 4.6). In both cases, there was no
correlation between amount or type of modification and trends in unmodified template
PCR efficiency. No statistically significant differences between PCR efficiencies were
observed between synthetic templates.
Table 4.6. PCR efficiencies from oligonucleotide templatesa.
Efficiency
ICR
Sample
1.01
Oxo CONTROL
0.990
OxodG1
1.01
OxodG2A
1.04
OxodG2T
1.06
OxodG3A
1.02
OxodG3T
1.01
OxodG4T
1.03
OxodG6
0.946
OxodA1
0.997
Abasic
1.01
Dimer CONTROL
0.996
TT Dimer1
a- PCR efficiencies were calculated using equation 15.

Efficiency
Full-length
0.936
0.943
0.922
0.954
0.963
0.991
0.986
0.989
0.968
0.946
0.962
0.975

To account for slight differences in input template amount, equation 16 was used
to generate x0 values representing input template fluorescence (Table 4.7). With the
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exception of the OxodG3T template (decreased by 87%), all calculated fluorescence
values for oligonucleotide templates differed less than 2-fold when compared to the Oxo
CONTROL. Most template x0 values were within 30% of one another. These values are
representative of input template fluorescence and accounted for any changes in E ICR or
input template amount between templates. Given the equivalent efficiencies (close to
1.0) for the ICR (Table 4.6), it is not surprising to see the same trends in calculated x0 as
were seen with relative input template amounts (Table 4.1). This observation implied
that the calculated input fluorescence corresponded to input template amount.

Table 4.7. Input template fluorescence.
Efficiency
Template
Unmodified
Fluorescence
Mean
Relative
CTa
Changed
(EICR)b
(Xo)c
Sample
10.1
1.01
8.64E-04
0.00%
Oxo CONTROL
9.57
0.990
1.38E-03
60.15%
OxodG1
9.47
1.01
1.36E-03
57.32%
OxodG2A
10.1
1.04
7.71E-04
-10.80%
OxodG2T
9.91
1.06
7.91E-04
-8.52%
OxodG3A
13.0
1.02
1.08E-04
-87.53%
OxodG3T
10.1
1.01
9.12E-04
5.53%
OxodG4T
10.2
1.03
7.35E-04
-14.99%
OxodG6
10.5
0.946
9.17E-04
6.08%
OxodA1
10.0
0.997
9.68E-04
12.04%
Abasic
10.3
1.01
7.64E-04
-11.56%
Dimer CONTROL
10.1
0.996
9.58E-04
10.90%
TT Dimer1
a- Mean CT values were calculated by averaging five amplifications of the ICR targets at a threshold (T)
of 1.0.
b- E ICR values were derived as described in Table 4.6.
c- x 0 values were calculated using equation 16.
d- Relative change determined by comparison to Oxo CONTROL data

Using the same data set from which the RTC efficiencies were derived (Tables
4.3-4.5), MMEs were calculated using equation 14 (Tables 4.8-4.10). The mean MME
efficiencies of the Oxo CONTROL and Dimer CONTROL templates were 0.776 and
1.28 respectively. These values represented 42.6% and 24.3% differences when
compared to the previously reported RTC efficiency values. It is important to note that
the confidence intervals for these data sets were much smaller demonstrating a more
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precise measurement (data not shown). Theoretically, the MMEs of the unmodified
controls should equal 1.0. The observed differences in MME from this theoretical mark
suggested that the inherent efficiencies of the ICR sequence differed from that of the fulllength template reaction and therefore an over- or underestimation of the MME occurred.
The decrease in MME below 1.0 in the Oxo CONTROL can be attributed to the
numerous stable secondary structures presented in Figure 4.9; the increase in MME
above 1.0 in the Dimer CONTROL could be due to increased SYBR Green Dye
incorporation as the target template in the full-length reactions is double that of the ICR
(discussed in Appendix B). Regardless of the reason, these differences point to the need
for sequence matched controls for any real-time analysis.
The OxodG1 and OxodG2A templates showed no significant difference in RTC
efficiency (Table 4.3). Calculated MMEs for both templates were 0.509 and 0.414,
equating to reductions of 34.4% and 46.6% respectively (Table 4.8; both significantly
different at p < 0.05). For all other templates, calculated MMEs followed similar patterns
to those seen in with the RTC estimations. Given this, plus the significant MME results
from the OxodG1 and OxodG2A templates, the simplified RTC formula was appropriate
to compare large differences in amplification rates, brought upon by DNA damage, where
as the more complex MME formula provided increased precision, which allowed small
damage influences on reaction rate to be detected.

74

Table 4.8. Mean modified efficiencies of templates with non-adjacent lesions.

Oxo CONTROL

OxodG1

OxodG2A

OxodG3A

OxodA1

Abasic

Xoa

Threshold
(T)

Efficiency
Unmodified
(Eu)b

Efficiency
Modified
(Em)c

Mean
Em

S.D.
Em

4.16

6.48E-02

1

0.936

0.925

0.776

0.0792

10fmole

7.17

1.09E-02

1

0.936

0.760

1fmole

11.0

8.65E-04

1

0.936

0.760

100amole

14.5

9.10E-05

1

0.936

0.720

10amole

17.8

1.07E-05

1

0.936

0.704

1amole

21.2

9.68E-07

1

0.936

0.789
0.509

0.113

0.414

0.140

0.0319

0.00600

0.1009

0.0245

0.0134

0.00250

Input
Template

Mean
CTM

100fmole

100fmole

4.32

9.57E-02

1

0.943

0.536

10fmole

6.81

1.65E-02

1

0.943

0.618

1fmole

11.1

1.38E-03

1

0.943

0.432

100amole

15.0

1.40E-04

1

0.943

0.328

10amole

17.3

1.60E-05

1

0.943

0.622

1amole

21.1

1.54E-06

1

0.943

0.518

100fmole

4.83

8.97E-02

1

0.922

0.418

10fmole

7.26

1.31E-02

1

0.922

0.613

1fmole

11.1

1.36E-03

1

0.922

0.475

100amole

14.5

1.49E-04

1

0.922

0.463

10amole

19.2

1.49E-05

1

0.922

0.223

1amole

22.5

1.31E-06

1

0.922

0.290

100fmole

9.19

4.40E-02

1

0.963

0.043

10fmole

12.4

7.80E-03

1

0.963

0.030

1fmole

15.8

7.91E-04

1

0.963

0.029

100amole

19.3

7.60E-05

1

0.963

0.028

10amole

22.8

7.58E-06

1

0.963

0.027

1amole

25.7

7.97E-07

1

0.963

0.035

100fmole

7.65

4.10E-02

1

0.968

0.128

10fmole

10.2

7.75E-03

1

0.968

0.127

1fmole

13.6

9.18E-04

1

0.968

0.104

100amole

16.9

1.01E-04

1

0.968

0.101

10amole

20.7

1.07E-05

1

0.968

0.0768

1amole

24.0

1.27E-06

1

0.968

0.0692

100fmole

10.4

4.86E-02

1

0.946

0.0179

10fmole

13.6

8.49E-03

1

0.946

0.0129

1fmole

17.1

9.71E-04

1

0.946

0.0108

100amole

20.6

8.71E-05

1

0.946

0.0117

10amole

23.9

9.02E-06

1

0.946

0.0127

1amole

27.2

8.81E-07

1

0.946

0.0143

a- X o values were calculated as described in Table 4.7
b- EU values were derived as described in Table 4.6
c- MMEs were derived using equation 14.
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Table 4.9. Mean modified efficiencies of templates with adjacent lesions a.
Input
Template
Oxo CONTROLb

OxodG2T

OxodG3T

OxodG4T

OxodG6

Mean
CTM

Xo

Threshold
(k)

Efficiency
Unmodified
(Eu)

Efficiency
Modified
(Em)

Mean
Em

S.D.
Em

0.776

0.0792

0.0171

0.0051

0.0045

0.0014

0.0045

0.0012

0.0007

0.0002

100fmole

4.16

6.48E-02

1

0.936

0.925

10fmole

7.17

1.09E-02

1

0.936

0.760

1fmole

11.0

8.65E-04

1

0.936

0.760

100amole

14.5

9.10E-05

1

0.936

0.720

10amole

17.8

1.07E-05

1

0.936

0.704

1amole

21.2

9.68E-07

1

0.936

0.789

100fmole

10.1

5.47E-02

1

0.954

0.0192

10fmole

13.6

7.65E-03

1

0.954

0.0140

1fmole

17.1

7.70E-04

1

0.954

0.0129

100amole

20.6

6.72E-05

1

0.954

0.0142

10amole

23.8

7.18E-06

1

0.954

0.0156

1amole

26.3

7.93E-07

1

0.954

0.0265

100fmole

14.4

1.04E-02

1

0.991

0.0046

10fmole

17.7

1.41E-03

1

0.991

0.0037

1fmole

21.4

1.08E-04

1

0.991

0.0037

100amole

24.7

1.20E-05

1

0.991

0.0034

10amole

27.6

1.24E-06

1

0.991

0.0043

1amole

30.1

1.32E-07

1

0.991

0.0073

100fmole

11.8

6.14E-02

1

0.986

0.0046

10fmole

15.2

7.23E-03

1

0.986

0.0040

1fmole

18.4

9.14E-04

1

0.986

0.0035

100amole

21.9

7.66E-05

1

0.986

0.0039

10amole

25.2

7.70E-06

1

0.986

0.0038

1amole

27.7

7.88E-07

1

0.986

0.0069

100fmole

14.8

5.25E-02

1

0.989

0.0007

10fmole

18.1

6.23E-03

1

0.989

0.0006

1fmole

21.5

7.35E-04

1

0.989

0.0005

100amole

24.8

5.99E-05

1

0.989

0.0006

10amole

28.2

6.32E-06

1

0.989

0.0006

1amole

30.3

6.72E-07

1

0.989

0.0013

a- Calculations were performed as described in Table 4.8.
b- Data from Table 4.8.
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Table 4.10. Mean modified efficiencies of templates with cis-syn TT dimers a.
Input
Template
Dimer CONTROL

TT Dimer1

Mean
CTM

Xo

Threshold
(k)

Efficiency
Unmodified
(Eu)

Efficiency
Modified
(Em)

Mean
Em

S.D.
Em

1.28

0.159

0.0091

0.0022

100fmole

4.11

5.35E-02

1

0.962

1.14

10fmole

6.62

7.98E-03

1

0.962

1.40

1fmole

10.1

7.64E-04

1

0.962

1.40

100amole

13.4

8.26E-05

1

0.962

1.41

10amole

16.7

9.34E-06

1

0.962

1.33

1amole

20.1

1.19E-06

1

0.962

1.04

100fmole

10.7

5.09E-02

1

0.975

0.012

10fmole

13.7

7.76E-03

1

0.975

0.011

1fmole

17.3

9.58E-04

1

0.975

0.0080

100amole

20.4

9.22E-05

1

0.975

0.0099

10amole

23.8

1.05E-05

1

0.975

0.0084

1amole

27.0

1.65E-06

1

0.975

0.0060

a- Calculations were performed as described in Table 4.8.

4.1.1.5. Lesion bypass rate: the Inherent Template Efficiency method

The use of standard curves to generate unmodified efficiency values was
necessary in obtaining precise estimates of DNA damage (MME and equation 6). The
generation of and subsequent amplification of standards is costly from both a time and
reagent perspective.

In an effort to eliminate the standard curve requirement, an

alternative mathematical treatment for real-time PCR data was adopted which calculates
input template amounts and efficiency values based on whole reaction curve kinetics
(142-143).

Mathematical formulae were developed to adapt this methodology to

compare amounts of DNA damage.
Raw PCR data was collected from a subset of the damaged oligonucleotides
(presented in Table 3.1) and then fit to a logistic/sigmoid curve from which variables
representing efficiency and input template amounts were derived. Using equation 23,
inherent template efficiencies (ITE) were calculated from these data (Table 4.11).
Values representing both ITE and PCR derived unmodified template efficiencies ( E PCR )
were determined. ITEs followed similar patterns seen in the RTC and MME data;
OxodG2T, OxodG4T, and OxodG6 dropped 98.0%, 99.6%, and 99.9% respectively when
compared with the Oxo CONTROL values (Table 4.11; all significant at p < 0.001).
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E PCR increased as the number of 8-oxodG modifications on the input template increased

(Table 4.11). These values were expected to remain constant between templates as the
value being measured, PCR derived unmodified template reaction efficiency, is thought
to be consistent between reactions.
Table 4.11. Inherent template efficiencies a.
Mean

Mean

Unmodified Efficiency

Inherent Template Efficiency

(EPCR)

(ITE)

Oxo CONTROL

0.482

0.201

OxodG2T

0.579

0.0040

OxodG4T

0.641

0.0007

OxodG6

0.711

0.0001

a- Means were calculated by averaging five amplifications of the ICR and full-length targets with input
amounts equal to 1 fmole at a threshold (T) of 1.0.

To determine the reason for the differences in observed E PCR , a serial dilution of
Oxo CONTROL templates was prepared and amplified. Variables necessary for input
into equation 23 to produce ITE and E PCR values were generated. The Rmax value (finite
plateau) is defined by the point at which no growth occurs in a reaction (Figure 4.11).
Recognizing that amplification curves for the oligonucleotide templates were not
achieving true plateau after 40 cycles, reaction data was collected out to the instrument
limit of 99 cycles. By increasing the amount of data used in the fit, the observation that
the raw PCR data did not produce a true fit to a logistic model became clear (Figure
4.11). The linear phases of the reactions (point at which the reaction curves exited
exponential growth and began to plateau) were not symmetric with the detectable
exponential growth phases in the data (point at which the curve data rises above
background; Figure 4.11). Notice the difference between the curve fit and raw data
increased as the amount of data points included increased; e.g. the variation between raw
and fit data during the initial ramping phase increases when 75 cycles of data are used
versus a fit from the same raw data cropped at 35 cycles (Figure 4.11). The result of this
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improper fit was variation in kinetic data ( Rmax , N 1 / 2 and K ), which ultimately produced
differences between derived input template and efficiency values from the same data set
∆CT

(Table 4.12). For calculation of input template, the values obtained using the 2-

comparison method closely paralleled those of the expected values with the greatest
discrepancy existing in the 10 fmole samples which differed by 35.9% (Table 4.12;
(141)).

Measures of input template Ro , derived from curve-fit data, differed greatly

from the expected values; an apparent difference that was influenced by the number of
data points used in the fit (Table 4.12). For example, in the samples containing 10 fmole
of input Oxo CONTROL, Ro35cyc , representing derived input template amounts using 35
cycle data, was 0.0101 fmoles and Ro75cyc was 0.0028 fmoles (representing 89.9% and
99.7% deviations from the expected value; Table 4.12). These data emphasize the need
for a proper curve-fit to PCR raw data and suggest the rate at which PCRs plateau must
be equivalent to the rate at which reactions proceed into detectable exponential phase to
authorize the use of curve-fitting methods of real-time PCR comparative analysis.
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(Rmax)

Figure 4.11. Kinetic analysis of raw PCR data. Variables derived from the logistic fit of raw PCR data
were influenced by the number of reaction cycles used in the curve fit; raw PCR data (
), fit curve
representing data cropped at 35 cycles ( * * ), and fit curve representing data cropped at 75 cycles
(
). The gradual plateauing toward a finite Rmax value in the raw data influenced the overall
shape of the fit curve as the number of cycles used in curve fitting increased.

80

Table 4.12. Comparison between 2-∆CT and curve-fit calculations.
Efficiency
Input

Unmodified
a

Efficiency
b

Efficiency

Input

Input

Template

Template

Template

c

(Ro75cyc) c

Expected

-∆CT

b

(2

)

(Ro35cyc)

Input

Template

(Eu)

(E35cyc)

10fmole

0.936

0.42

0.32

13600

1020

27.8

10000

1fmole

0.936

0.43

0.32

1230

243

9.40

1000

100amole

0.936

0.47

0.30

120

45.4

4.97

100

10amole

0.936

0.44

0.29

11.1

7.97

1.83

10.0

8amole

0.936

0.45

0.28

9.08

6.52

1.75

8.00

6amole

0.936

0.44

0.27

5.82

5.41

1.57

6.00

4amole

0.936

0.46

0.28

4.63

3.85

1.51

4.00

2amole

0.936

0.46

0.26

1.91

2.23

1.35

2.00

1.00

1.00

1.00

1.00

(E75cyc)

1amole
0.936
0.49
0.27
a- EU values were derived as described in Table 4.6

b- E 35cyc and E 75cyc were derived from curve-fit data cropped at 35 and 75 cycles respectively.
c- Ro35 cyc and Ro75cyc represent input template amounts derived from 35 and 75 cycle curve-fit data and
normalized to 1 amole.

To correct for this lack of curve symmetry, experimental design was created to
limit a single reaction component, thereby creating a unique rate-limiting step in the
PCR, and forcing amplification curves to plateau at a much greater rate. As stated in the
materials and methods section, PCRs contain 1 µl of 10 µM forward and reverse primers
which was estimated to be approximately 300 nmoles of each per reaction (data not
shown). Reactions with primer amounts ranging from 30 to 300 nmoles were amplified;
the rates of plateau and corresponding curve-fits were observed (Figure 4.12; data not
shown). Decreasing both primer amounts to 37.5 nmoles provided a better fit to raw
PCR data using both 40 and 50 cycles of data when compared with that of the 300 nmole
primer reactions (Figure 4.12).
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Figure 4.12. Real-time PCR raw data fit to a logistic curve. (**) represent raw data points, (-) are the
data post logistic fit. Reactions containing 300 nmoles of total primer present a divergence between the fit
and raw data; this divergence increased as the amount of raw data used in the fit is increased from A) 40 to
B) 50 cycles. Decreasing the amount of primer to 37.5 nmoles lessened the degree of difference between
raw and curve-fit data using both C) 40 and D) 50 cycles of data.

Values for efficiency and input template were derived from curve-fit data from reactions
containing 300 and 37.5 nmoles of forward and reverse primers (Table 4.13). The
difference between the normalized Ro and expected values was not as dramatic in the
reactions where primer amounts were the rate-limiting step; for example, in reactions
with 10 fmoles of input oligonucleotide, 300 nmoles of primer produced normalized
Ro40 cyc and Ro50cyc of 3.23 and 2.97 fmoles where normalized values for 37.5 nmoles

were 5.512 and 5.141 fmoles (Table 4.13). Values for unmodified efficiency increased
from approximately 0.32 to 0.46 when primer amounts were limited (Table 4.13).
While decreasing primer amounts provided results closer to expected values,
accuracy and precision are critical for the evaluation of damaged template. Curve-fit
methods, in their current format, could not be adapted for reliable measurement of DNA
damage in synthetic template.

Derivation of new formulae characterizing the
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discrepancies between raw and curve-fit data is necessary before the utilization of these
methods for DNA damage detection is achieved.
Table 4.13. Curve-fit calculations from reactions with differing primer amountsa.
Primer
Concentration

Template
Amount

Efficiency
(E40cyc)

Efficiency
(E50cyc)

Input
Template
(Ro40cyc) b

Input
Template
(Ro50cyc) b

Expected

300nmole
300nmole
300nmole
300nmole
300nmole
300nmole
300nmole
300nmole
300nmole

10fmole
8fmole
6fmole
4fmole
2fmole
1fmole
100amole
10amole
1amole

0.34

0.31

3.23

2.97

10.0

0.34

0.31

2.59

2.28

8.00

0.32

0.29

2.81

2.64

6.00

0.34

0.30

1.94

1.98

4.00

0.35

0.32

1.37

1.36

2.00

0.36

0.32

1.00

1.00

1.00

0.35

0.31

0.340

0.440

0.100

0.36

0.30

0.100

0.170

0.010

0.32

0.27

0.040

0.090

0.001

Primer
Concentration

Template
Amount

Efficiency
(E40cyc)

Efficiency
(E50cyc)

Input
Template
(Ro40cyc) b

Input
Template
(Ro50cyc) b

Expected

37.5nmole
37.5nmole
37.5nmole
37.5nmole
37.5nmole
37.5nmole
37.5nmole
37.5nmole
37.5nmole

10fmole
8fmole
6fmole
4fmole
2fmole
1fmole
100amole
10amole
1amole

0.46

0.45

5.52

5.14

10.0

0.46

0.45

4.49

4.05

8.00

0.45

0.44

4.13

3.88

6.00

0.51

0.49

1.97

1.95

4.00

0.48

0.46

1.57

1.64

2.00

0.48

0.46

1.00

1.00

1.00

0.45

0.43

0.270

0.290

0.100

0.42

0.39

0.080

0.110

0.010

0.34

0.30

0.050

0.100

0.001

a- E cyc and Rocyc values were derived as described in Table 4.12.
b- Rocyc values were normalized to 1 fmole data.

4.1.1.6. Alternative PCR components increase lesion bypass rate

A subset of 90-mer oligonucleotides were amplified using the Restorase DNA
polymerase system (Sigma) to determine if changes in the PCR reagents impacted
observed RTC efficiencies. Restorase DNA polymerase is a mixture of Sigma AccuTaq
LA and a proprietary DNA damage repair enzyme that is thought to be specific for the
repair of abasic lesions (165). RTC efficiencies were calculated from real-time data.
Oxo CONTROL, OxodG2A, OxodA1, and Abasic mean RTC efficiencies were 0.614,
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0.460, 0.611, and 0.0298 respectively (Table 4.14). While neither the OxodG2A nor
OxodA1 RTC efficiencies differed significantly from those of the Oxo CONTROL, the
Abasic RTC efficiency dropped 95.1% (significantly different at p < 0.001).
When compared with amplifications using AmpliTaq Gold (Table 4.3; Applied
Biosystems), no significant differences were seen between RTC efficiencies from Oxo
CONTROL or OxodG2A amplifications (Figure 4.13). However, when using Restorase,
OxodA1 RTC efficiencies increased from 0.114 to 0.611 (levels mimicking the control
reactions; Figure 4.13; significantly different at p < 0.001). Abasic RTC efficiencies
were also increased; from 0.009 to 0.029 (Figure 4.13; significantly different at p < 0.05).
These data suggested that the PCRs with Restorase and matching reagents were more
efficient than AmpliTaq Gold protocols at processing templates with 8-oxodA and abasic
lesions.
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Table 4.14. RTC efficiencies from PCRs with Restorase DNA polymerasea.

Oxo CONTROL

OxodG2A

OxodA1

Abasic

a- CTU ,

Input
Template

Mean
CTU

Mean
CTM

∆CT

1fmole

11.6

1fmole

11.8

1fmole
1fmole

(U-M)

RTC

Mean
RTC

S.D.

C.V.

12.6

-0.949

0.518

0.614

0.0862

0.14

12.3

-0.536

0.690

12.1

12.6

-0.547

0.685

11.8

12.6

-0.824

0.565

1fmole

11.1

12.0

-0.898

0.537

0.460

0.134

0.29

1fmole

11.1

11.9

-0.792

0.578

1fmole

11.1

12.3

-1.16

0.449

1fmole

10.4

12.3

-1.86

0.276

1fmole

11.7

12.4

-0.688

0.621

0.611

0.0959

0.16

1fmole

11.6

12.0

-0.477

0.719

1fmole

11.3

12.4

-1.04

0.485

1fmole

11.7

12.4

-0.692

0.619

1fmole

11.0

15.7

-4.70

0.0384

0.0298

0.0074

0.25

1fmole

10.5

16.1

-5.62

0.0203

1fmole

11.4

16.5

-5.02

0.0308

1fmole

11.4

16.5

-5.08

0.0296

CTM , RTC, and C.V. were calculated as described in Table 4.3.

Figure 4.13. RTC efficiencies from PCRs using AmpliTaq Gold and Restorase. RTC efficiencies from
Oxo CONTROL, OxodG2A, OxodA1 and Abasic templates were calculated from PCRs using either
AmpliTaq Gold (average of 6 DNA template amounts, each with N=5) or Restorase DNA polymerase (1
template amount; N=4) master mixes.
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4.1.1.7. Lesion bypass rate: long template amplification

To transition from real-time damage quantification from short synthetic templates
to quantification of damage in cellular DNA, amplicon target size must be increased and
assay sensitivity must be determined. Instrument limitations do not permit the usage of
PCR extension times comparable to Taq DNA polymerase processivity (reported to be as
high as 2.8 kb per minute or less than 5 s to traverse 90 bases; (146)). Therefore, to
estimate the sensitivity of real-time polymerase stop assays for damage detection, longer
templates with controlled modification were necessary. To study the influence of base
modifications under native polymerase conditions, a subset of the synthetic 90 base
oligonucleotides were used as primers and ligated into PCR products (Figure 4.14). To
remove the original template and anti-sense strand, PCR products were separated using
biotin:streptavidin association (Figure 4.14B).

Primers were designed and used to

amplify a full-length 593 base template (Figure 4.14C) and a ligated oligo internal control
region (LO-ICR) containing no base modification (Figure 4.14D). Extension times in
these PCRs were 1 min; still in excess of the time necessary to replicate the templates but
not to the degree seen with the 90-mer oligonucleotides. MMEs for the control templates
were 0.559 (Oxo CONTROL) and 0.819 (Dimer CONTROL) (Table 4.15). MMEs from
reactions with 8-oxodG modifications showed a steady trend lower as the number of base
modifications increased; OxodG1, OxodG2A, and OxodG3A had MMEs of 1.03, 0.739,
and 0.514 respectively (Table 4.15). The OxodA1 template generated a MME of 0.614;
which mimics trends in the 90-mer data when compared with the OxodG2A and
OxodG3A templates but not when compared with the Oxo CONTROL (Table 4.15).
Abasic and TT Dimer1 containing templates substantially altered their respective
reactions; generating MMEs of 0.062 and 0.014, similar to those observed in the short
template data (Table 4.15).
While these modified templates present decreasing trends similar to those
observed with the 90-mer data, the differences with respect to the Oxo CONTROL are
not easily explained. The data suggests that multiple factors influenced the kinetics of
these PCRs. The decrease in the Oxo CONTROL MME can be partially explained by the
previously mentioned secondary structures (Figure 4.9) which may play a role in limiting
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primer annealing. In the 8-oxodG reactions, it is possible that the insertion of the base
modifications altered the backbone dynamics in the single stranded template (159), which
decreased stable secondary structures, and therefore increased observed MMEs. Then, as
the number of 8-oxodGs was increased, the influence of 8-oxodG base modification on
Taq DNA polymerase progression became evident.

A

*
B

B
B

PMP

*
C
D

Figure 4.14. Creation of long templates containing controlled DNA base modification. A) To increase
the availability of template for modified oligonucleotide ligation, 751 bp PCR products were created from
human mtDNA. Modified and unmodified 90-mers were then used as primers to amplify a 593 bp nested
PCR target; the forward primer in these reactions was labeled with biotin. B) 593 bp PCR products,
containing the 90-mers, were associated with streptaviden coated magnesphere beads (Promega), collected,
and denatured; the sense strands containing the 90-mers were collected and used as templates in C) fulllength PCRs (593 bp) or D) LO-ICR reactions (545 bp). (*) represents modified nucleotides; (
)
represents synthetic oligonucleotide containing sense strand; (
) represents biotin containing antisense strand; (
) represents PCR sense strand; (
) equals PCR anti-sense strand.
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Table 4.15. Mean modified efficiencies from long templatesa.
Mean
MME
Oxo CONTROL
0.559
OxodG1
1.04
OxodG2A
0.739
OxodG3A
0.514
OxodA1
0.614
Abasic
0.062
Dimer CONTROL
0.819
TT Dimer1
0.0144
a- MMEs were derived using equation 14 as described in Table 4.8.

S.D.
MME
0.0849
0.0718
0.0309
0.0382
0.0428
0.0354
0.0585
0.0002

4.1.2. Quantification of cellular DNA damage

To this point, quantification of DNA damage has involved 90-mer
oligonucleotides with set amounts and types of base damage. In order to be useful as a
general research tool to study DNA damage and repair, characterization of damage in
cellular DNA sample material must be achieved. Given that the majority of damage
events to DNA are random, the sensitivity of polymerase stop assays in detecting damage
increases with the size of the PCR amplicon (5, 11). To validate real-time PCR as a
method to estimate damage in cellular DNA, primers were designed to amplify a segment
of human mtDNA; by holding the reverse primer constant and moving the forward
primer, amplicon sizes were increased and observed differences in the PCRs attributed to
differences in amounts of DNA damage (Figure 4.15).
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REV #14841

Amplicon 1 (221 bp)

Amplicon 2 (371 bp)

mtDNA

Amplicon 5 (1654 bp)

Amplicon 7 (3082 bp)

Figure 4.15. Amplification of mitochondrial DNA by primer walking. The schematic represents a
model of mammalian mtDNA; reverse primer (REV #14841) was held constant and forward primers
moved to create amplicons ranging between 221 bp and 3082 bp. Actual fragment size is given in
parenthesis.

Prior to damage estimation, it was first necessary to validate the use of long
cellular DNA targets in PCRs on the ABI 7000 sequence detection system. To do so,
three amounts of total cellular DNA (4.5 ng, 9.0 ng, and 13.5 ng) were amplified with
different primer sets ranging from 200 bp to 8.0 kb (Figure 4.15; data not shown). Input
template fluorescence was calculated using equation 16 and normalized to the 4.5 ng
DNA sample data (Table 4.16).

For amplicons up to 3.0 kb, normalized template

fluorescent amounts mirrored the expected values (Table 4.16). For amplicons greater
than 4.0 kb, the reliability of Xo calculations were found to be inconsistent and therefore
not sufficient for further experimentation (data not shown). These data suggested that the
real-time PCR protocols presented here were adequate for amplification of DNA targets
up to 3.0 kb.
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Table 4.16. Input template fluorescence at different amplicon sizes.
Input
Templatea

Xob

Normalized
Xo

Expected

4.5 ng

1.57E-08

1.00

1.00

9.0 ng

3.12E-08

1.99

2.00

13.5 ng

4.71E-08

3.00

3.00

4.5 ng

4.60E-08

1.00

1.00

9.0 ng

9.08E-08

1.97

2.00

13.5 ng

1.38E-07

3.01

3.00

4.5 ng

2.16E-08

1.00

1.00

9.0 ng

4.31E-08

2.00

2.00

13.5 ng

6.47E-08

3.00

3.00

4.5 ng

1.82E-09

1.00

1.00

9.0 ng

3.79E-09

2.09

2.00

13.5 ng

5.41E-09

2.98

3.00

Amplicon 1

Amplicon 2

Amplicon 5

Amplicon 7

a- Estimated using optical density at 260nm.
b- Xos were derived using equation 16 as described in Table 4.7.

Extracted total cellular DNA was irradiated at 254 nm for various times and then
amplified using real-time PCR. Rightward shifts in amplification curves were observed
(data not shown). Input template amounts were held constant and input fluorescent
values calculated for each amplicon size using non-irradiated controls; therefore, any
differences in amplification (observed changes in CT values) can be defined as
differences in amounts of DNA damage (151). Using the mean modified efficiency
calculation method, a decrease in amplification was observed that correlated to increased
PCR product size and increased time of exposure to UV radiation (Table 4.17). To
account for inherent differences in amplification between different sized templates
(including differences in the efficiencies of PCR derived unmodified templates and
different amounts of fluorescent dye incorporation (Appendix B)), MMEs were
normalized to untreated controls at each amplicon size. While the normalized MME
from the amplification of Amplicon 1 (221 bp) was 0.786 after 0.5 min of exposure,
Amplicons 2 (371 bp), 5 (1654 bp), and 7 (3082 bp) had normalized MMEs of 0.793,
0.175, and 0.128, respectively (Table 4.17). Doubling the exposure time decreased
normalized MMEs to 0.716, 0.413, 0.068, and 0.028 for Amplicons 1, 2, 5, and 7
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respectively (Table 4.17). Further decreases in normalized MMEs were observed as
exposure times were increased (Table 4.17). Amplification in the no template controls,
as a result of stable primer dimer formation, provided an experimental baseline value for
MMEs which was specific for each primer set (data not shown). These results are
consistent with reports that the sensitivity of polymerase stop based assays increases with
the size of the PCR target (5, 11) and also suggest that real-time PCR can be used to
estimate damage in cellular DNA.
Cellular DNA does not contain templates with homogenous damage in a
particular target region; more appropriately, cellular DNA is a mixture of damaged and
undamaged template. Both the MME and RTC are rate based methods of estimating
DNA damage and assume no unmodified templates exist at the beginning of the PCR
(151). Therefore, the observed changes in CT values from damaged sample PCRs, it was
necessary to redefine damage in terms of probability rather than reaction rate (10);
equation 26 was developed which defined differences in CT values as lesion frequency
(proportion of damaged bases in treated sample material). Using equation 26, lesion
frequencies were calculated from data used to generate MMEs for UV irradiated cellular
DNA (Table 4.18). Lesion frequencies increased as the time of UV exposure increased
in all amplicon sizes tested (Table 4.18). Lesion frequencies seemingly decreased as
amplicon size increased; this was not expected as UV damage to DNA is assumed to be
random and should, therefore, increase with fragment size. This apparent decrease could
be explained by increased precision in lesion frequency estimation at longer template
lengths; increased precision was a result of an observed decrease in unmodified reaction
efficiencies (Eu values), which resulted in an increase (spread out) in CT values.

This

finding suggested that damage studies involving short fragments were unreliable; even at
excessive UV exposure dosages.
While these studies were encouraging and suggested that damage to DNA could
be measured using real-time polymerase stop assays, further refinement of amplicon
targets and the use of samples enduring biologically relevant amounts of UV exposure
were necessary to determine the applicability of these methods in clinical and research
settings.
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Table 4.17. Mean modified efficiencies from UV irradiated DNA.
Normalized
MMEb

Sample
Amplicon 1
Amplicon 2
Amplicon 5
Amplicon 7

Exposurea

MME

0

0.943

1

0

1.04

1

0

0.967

1

0

0.869

1

Amplicon 1
Amplicon 2
Amplicon 5
Amplicon 7

0.5

0.741

0.786

0.5

0.822

0.793

0.5

0.169

0.175

0.5

0.112

0.128

Amplicon 1
Amplicon 2
Amplicon 5
Amplicon 7

1

0.675

0.716

1

0.428

0.413

1

0.0658

0.0680

1

0.0241

0.0278

Amplicon 1
Amplicon 2
Amplicon 5
Amplicon 7

3

0.499

0.530

3

0.253

0.244

3

0.0109

0.0113

3

0.00240

0.0028

Amplicon 1
Amplicon 2
Amplicon 5
Amplicon 7

7

0.309

0.328

Amplicon 1
Amplicon 2

15

0.178

0.189

15

0.0439

0.0424

Amplicon 5c

15

0.0002

0.0002

7

0.170

0.164

7

0.0020

0.0021

7

0.0004

0.0004

c

Amplicon 7
15
0.0002
0.0002
a- Listed in minutes of exposure to 254 nm UV radiation.
b- Normalized to the control sample to account for inherent differences between template sizes.
c- Samples approached background MME values as exposure times increased; background MMEs were
derived from no template controls and were a result of primer-dimer amplification (data not shown).
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Table 4.18. Lesion frequencies from UV irradiated DNA.

Exposurea
Amplicon 1
(N=221)

Amplicon 2
(N=371)

Amplicon 5
(N=1654)

Amplicon 7
(N=3082)

CT Meanb

CT S.D.

∆CT

Unmodified
Efficiency
(Eu)c

Lesion
Frequencyd

L.F./10 kb

0

17.5

0.137

0.000

0.950

0.5

18.0

0.0730

-0.516

0.950

0.0016

16

1

18.1

0.251

-0.626

0.950

0.0019

19

3

18.8

0.403

-1.36

0.950

0.0041

41

7

19.2

0.0350

-1.77

0.950

0.0053

53

15

20.3

0.159

-2.85

0.950

0.0086

86

0

17.7

0.0880

0.000

0.900

0.5

18.1

0.0950

-0.326

0.900

0.00056

5.6

1

18.2

0.133

-0.492

0.900

0.00085

8.5

3

19.7

0.919

-1.98

0.900

0.0034

34

7

20.3

0.0310

-2.54

0.900

0.0044

44

15

22.2

0.316

-4.44

0.900

0.0077

77

0

18.3

0.119

0.000

0.751

0.5

19.5

0.0650

-1.28

0.751

0.00043

4.3

1

20.9

0.262

-2.67

0.751

0.00090

9.0

3

23.6

0.0330

-5.33

0.751

0.0018

18

7

26.1

0.301

-7.81

0.751

0.0026

26

15

31.7

0.298

-13.4

0.751

0.0045

45

0

21.1

0.143

0.000

0.650

0.5

23.3

0.160

-2.25

0.650

0.00036

3.6

1

25.8

0.232

-4.70

0.650

0.00076

7.6

3

29.5

0.181

-8.38

0.650

0.0014

14

7

32.4

1.04

-11.4

0.650

0.0018

18

15

33.6

0.770

-12.5

0.650

0.0020

20

a- As described in Table 4.17.
b- Mean CTs were calculated from an N=3 at threshold of 1.0.
c- Calculated using equation 15.
d- Calculated using equation 26 (listed per base).

4.1.2.1. Validation of real-time PCR to estimate biologically relevant UV DNA damage

In order to establish if changes in CT values could be detected from biologically
relevant amounts of UV DNA damage and translated into lesion frequencies, damaged
cellular DNA was acquired from Drs. Bennett Van Houten and Joel Meyer; lesion
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frequencies were estimated using conventional QPCR (11). Three template samples were
generated by exposing MGH-U1 bladder carcinoma cells to 0, 10 or 20 J/m2 UV
radiation and extracting total cellular DNA. Using the QPCR method, lesion frequencies
of these samples (designated 0 L, 0.5 L and 1.0 L respectively) were estimated to be 0,
0.5 and 1 lesion per 10,000 bp. To determine if polymerase stop assays for DNA damage
quantification could be adapted for use on a real-time PCR platform, the primer walking
strategy was adapted as described in sections 3.2.2.2. and 4.1.2. (Figure 3.4, 4.15). By
holding the reverse primer constant and moving the position of the forward primer, four
fragment lengths were amplified ranging from 700 bp to 2.25 kb (Table 4.19).
This method relies on the assumption that templates containing one or more
damaged bases do not contribute to the PCR, and so for reactions with equal input
template quantities, samples with damage will show higher CT values than samples with
no damage. For a given lesion frequency, the probability that any input template contains
a damaged base increases as the template length increases. Thus the difference in CT
values (∆CT) between undamaged and damaged samples will be higher for longer
templates.
For each sample at each template length, ∆CTs were computed, along with 95%
confidence intervals for these ∆CT values (Table 4.19). Where the confidence interval
does not contain the value zero, a significant difference between the CT value for the
damaged sample and that for the undamaged sample was inferred. Significant differences
could also be predicated based on a relatively low standard deviation within samples
(data not shown). ∆CTs were determined from two independent real-time PCR data sets.
For the first data set, significant differences between 0 L and 1.0 L samples were inferred
at all template lengths (Table 4.19). Significant differences between 0 L and 0.5 L
samples were inferred at template lengths of 1654 bp and 2241 bp, but not at template
lengths of 693 bp or 942 bp (Table 4.19). For the second data set, significant differences
were inferred between both damaged samples and the undamaged sample at all template
lengths (Table 4.19). The standard deviations of CT values were generally lower in the
second data set, particularly for the shorter template lengths and may have provided a
degree of precision necessary to calculate significance (Table 4.19).
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Lesion frequencies were computed for both damaged samples (0.5 L and 1.0 L) at
each template length and for each data set, using equation 26 (Table 4.19). The variation
between data sets was smaller at templates lengths of 1654 and 2241 bp than at the
shorter template lengths of 693 bp and 942 bp, consistent with the confidence interval
analysis. Lesion frequency estimates using this method were generally 2-fold to 3-fold
higher than the estimates of 0.5 lesions and 1.0 lesions per 10,000 bases provided by
QPCR.

4.1.2.2. Lesion bypass does not affect estimation of lesion frequencies in simulated data

Data presented by Sikorsky et al. (2004) suggest the assumption that damaged
templates are completely blocked in the PCR is not technically correct, and that damaged
templates contribute to the PCR with reduced efficiency ED (151).

For templates

containing single cis-syn thymine-thymine dimers, ED is on the order of 1% (151). In
order to test the significance of this effect on lesion abundance calculations, a range of
simulated lesion bypass efficiencies from damaged templates were created and, using
equation 27 with each estimate, lesion frequencies were computed (Table 4.20; for full
derivation of equation 14, see Appendix E). With simulated efficiencies in the range 0%5%, differences in the computed lesion frequency were less than 10% (Table 4.20).
Therefore, assuming that templates with UV lesions in the target region did not contribute
to the reaction was valid in these lesion abundance calculation experiments.
Other types of DNA base modifications, such as 8-oxodG and 8-oxodA, allow
lesion bypass at a much higher rate (151). Without an independent, and accurate,
measurement of lesion bypass rate, the method presented here is unsuitable for the
measurement of such damage. In theory, it is possible to compare ∆CT values from
reactions at two different amplicon lengths and simultaneously calculate both lesion
frequency and lesion bypass rate (Appendix F). However, at this time, current limitations
in instrumentation and fluorescent detection do not provide the precision necessary to
perform these assays.
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Table 4.19. Lesion frequencies calculated using real-time QPCR.
Sample
Name
Amplicon 3
(N= 693)

Amplicon 4
(N=942)

Amplicon 5
(N=1654)

Amplicon 6
(N=2241)

CNTL#1

CT Meana
18.1

CT S.D.

∆CT

0.157

0.000

Significantb

Unmodified
Efficiency
(Eu)

Lesion
Frequencyc

Mean
L.F.

S.D.
L.F.d

0.891

0.5L #1

18.1

0.149

-0.0460

No

0.891

0.42

1.1

0.90

1.0L #1

18.5

0.153

-0.394

Yes

0.891

3.6

3.2

0.54

CNTL#2

17.8

0.100

0.000

0.5L #2

18.0

0.087

-0.184

Yes

0.891

1.7

1.0L #2

18.1

0.032

-0.310

Yes

0.891

2.8

CNTL#1

18.2

0.139

0.000

0.891

0.849

0.5L #1

18.4

0.223

-0.202

No

0.849

1.3

1.7

0.60

1.0L #1

18.7

0.243

-0.486

Yes

0.849

3.2

4.0

1.1

CNTL#2

18.5

0.134

0.000

0.5L #2

18.8

0.151

-0.332

Yes

0.849

2.2

1.0L #2

19.2

0.351

-0.736

Yes

0.849

4.8

CNTL#1

19.4

0.229

0.000

0.5L #1

19.7

0.162

-0.344

Yes

0.751

1.2

1.4

0.35

1.0L #1

20.1

0.200

-0.755

Yes

0.751

2.6

2.7

0.27

CNTL#2

19.5

0.111

0.000

0.5L #2

20.0

0.134

-0.489

Yes

0.751

1.7

1.0L #2

20.4

0.208

-0.866

Yes

0.751

2.9

CNTL#1

20.6

0.177

0.000

0.5L #1

21.3

0.471

-0.703

Yes

0.692

1.7

1.3

0.49

1.0L #1

21.6

0.0980

-0.938

Yes

0.692

2.2

2.2

0.059

CNTL#2

21.0

0.0590

0.000

0.5L #2

21.5

0.0950

-0.411

Yes

0.692

0.97

1.0L #2

21.9

0.0540

-0.903

Yes

0.692

2.1

0.849

0.751

0.751

0.692

0.692

a- Mean CTs were calculated from an N=4 at threshold of 1.0.
b- Significance of mean CT , using a 95% confidence interval, as established by comparing treated versus control
samples (see materials and methods).
c- Calculated using Equation 26 and listed as lesion per 10000 bases.
d- S.D. is the standard deviation of the LF calculations.
e- Amplicons 1 and 2 are not shown.
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Table 4.20. Influence of lesion bypass (ED) on lesion frequency (p) estimationa.
0.5 L Sample
Target Base Length
942
1654

Simulated ED

693

0%

1.7

2.2

1.7

2241
0.97

0.1%

1.7

2.2

1.7

0.97

0.2%

1.7

2.2

1.7

0.97

0.5%

1.7

2.2

1.7

0.97

1%

1.7

2.2

1.7

0.98

2%

1.7

2.2

1.7

1.0

5%

1.8

2.3

1.8

1.1

10%

1.9

2.5

2.0

1.2

1.0 L Sample
Target Base Length
942
1654

Simulated ED

693

0%

2.8

4.8

2.9

2241
2.1

0.1%

2.9

4.8

2.9

2.1

0.2%

2.9

4.8

2.9

2.1

0.5%

2.9

4.8

3.0

2.1

1%

2.9

4.9

3.0

2.2

2%

2.9

4.9

3.0

2.2

5%

3.0

5.2

3.2

2.3

10%

3.3

5.6

3.5

2.6

a- Lesion frequencies are computed using equation 27, using the EU, CU, and CD values from Table
4.19 and presented as lesions per 10000 bases.
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4.2. Characterization of Lesion Induced PCR Mutation
When present in synthetic templates, 8-oxodG, 8-oxodA, and abasic sites are
known to retard but not absolutely block extension by the Klenow fragment of E. coli
DNA polymerase I (2, 18, 51, 68) and Taq DNA polymerase is able to slowly bypass cissyn thymidine dimers (87). These properties are consistent with observations presented

above that replication of some damaged templates is impeded, but not absolutely blocked,
during early rounds of the PCR (151).

4.2.1. Melt curves of PCR products from damaged template suggest multiple products

One benefit of amplifying DNA in real-time using SYBR green dye detection is
the ability to generate dissociation curves of PCR products to determine melting
temperature and the presence of spurious product formation. Annealing kinetics of
duplex DNA are mainly influenced by interstrand hydrogen bonding (113); differences in
nucleotide sequences can result in changes in duplex melting temperatures. To determine
the melting temperatures of PCR products generated from amplification of 90-mer
oligonucleotide templates, dissociation curve profiles were generated (Figure 4.15). Oxo
CONTROL templates generated PCR products with a unique peak suggesting the
formation of a single product; the melting temperature for this 90 bp sequence was
approximately 75o C (Figure 4.16). As the amount of 8-oxodG modifications increased
in the input oligonucleotide, the ability to resolve definitive peaks in the dissociation
curves decreased (OxodG2T, OxodG4T, and OxodG6; Figure 4.16). Dissociation curves
from OxodG1, OxodG2A, and OxodG3A templates mimicked those of the Oxo
CONTROL (data not shown). These observations implied that multiple products were
formed in the PCRs of templates with increased 8-oxodG lesions.
PCR products from OxodA1 templates generated a unique peak with decreased
amplitude when compared with that of the Oxo CONTROL (Figure 4.16).

This

suggested the majority of PCR product formed in these reactions had similar melting
temperatures to those from the controls.

The Abasic template profiles were less

definitive; at least three peaks were observed, one of which occurred at a point similar to
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the Oxo CONTROL (Figure 4.16). These data indicated that multiple products were
formed as a result of abasic site bypass.

Figure 4.16. Dissociation curves of PCR products from modified oligonucleotides. Melting
temperatures of PCR products from the amplification of 90-mer Oxo CONTROL oligonucleotides were
approximately 75o C. The amount and type of modification influenced the ability to resolve definitive
peaks in the dissociation profiles; all graphs represent N=5.

4.2.2. The fidelity of Taq polymerase is influenced by lesions on the input DNA
template.

To determine if lesions on the oligonucleotide templates influenced nucleotide
incorporation, the real-time PCR products from modified oligonucleotide amplifications
were purified and the sequences determined (Figures 4.17-4.20; summarized in Table
4.21; data not shown). The forward amplification primer was used to sequence the PCR
products. This primer binds to the complement of the input oligonucleotide used and
therefore any sequence obtained is suggestive of lesion bypass and full-length product
formation. Sequence data from all oligonucleotides tested is summarized below (Table
4.21).
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The Oxo CONTROL and Dimer CONTROL matched their expected sequences
(Figure 4.17; 4.20A). In all templates with 8-oxodG lesions, a mixture of reaction
products was obtained (Figure 4.18). The majority of amplicons contained the normal
Watson-Crick insertion of dCMP opposite the lesion site; the minority amplicon
sequence from most 8-oxodG containing templates included dAMP pairing opposite the
base lesion, creating a stable transversion [guanine to thymine] (Figure 4.18). When two
8-oxodGs were adjacent on the input template, in addition to the incorporation of dCMP
and dAMP opposite the lesion sites, a pronounced n-1 deletion event occurred (Figure
4.18).

The addition of subsequent adjacent 8-oxodGs resulted in indistinct product

sequences (Table 4.21; data not shown).

Figure 4.17. Sequence analysis of PCR product from Oxo CONTROL oligonucleotide. Black, green,
red, and blue represent guanine, adenine, thymine, and cytosine bases respectively. PCR product sequences
from the amplification of 90-mer Oxo CONTROL oligonucleotides were equivalent to the expected input
synthesis sequence; neither failed synthesis products nor PCR derived mutations were detected.
Background fluorescence was observed and could be attributed to increased peak amplitude resulting from
excess fluorescent dye incorporation.
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A

*

B

*

C

*

*

*

*

D

Figure 4.18. Sequence analysis of PCR product from oligonucleotides containing 8-oxodG base
modifications. Black, green, red, and blue represent guanine, adenine, thymine, and cytosine bases
respectively. Amplification of 90-mer oligonucleotides, A) OxodG1, B) OxodG2A, C) OxodG3A, and D)
OxodG2T, resulted in multiple PCR products; sites of DNA modification are designated (M) in the
sequence header. In all products examined, G!T transversions at the site of modification were observed
(*). In addition, two adjacent 8-oxodGs (OxodG2T) resulted in n-1 deletion products (solid down arrows).

Amplicons created by replication through 8-oxodA were also mixed.

The

predominant sequence generated contained the incorporation of dTMP opposite the lesion
site (Figure 4.19A). In addition, a pronounced n-1 deletion occurred during amplicon
synthesis, originating opposite the 8-oxodA (Figure 4.19A). Nucleotide incorporation
opposite single abasic sites also resulted in mixtures of amplicons (Figure 4.19B); n-1
deletions, n+1 insertions, and a mixture of dNMP incorporations were observed. Base
association across from single thymine dimer modifications and subsequent strand
extension were not clear (Figure 4.20B). While the predominate base incorporated
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opposite the TT Dimer modification appeared to be dCMP, an unambiguous
characterization of extension products could not be determined (Figure 4.20B). Like that
seen in products from multiple adjacent 8-oxodGs (greater than 3), this ambiguity can be
attributed to the presence of multiple extension products (deletions and insertions), none
of which could be considered a majority sequence, which disrupt the dye terminator
sequencing reactions.

A

B

#

#

Figure 4.19. Sequence analysis of PCR product from oligonucleotides containing 8-oxodA and abasic
base modifications. Black, green, red, and blue represent guanine, adenine, thymine, and cytosine bases
respectively. Amplification of 90-mer oligonucleotides, A) OxodA1, and B) Abasic templates resulted in
multiple PCR products; sites of DNA modification are designated (M) in the sequence header. In addition
to the majority sequence (dTMP incorporation opposite modification), a pronounced n-1 deletion originated
at the 8-oxodA site (dashed down arrows). Guanine is present at the site of modification in PCR products
from Abasic template (suggesting dCMP incorporation); in addition, minority peaks were observed (#).
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A

B

Figure 4.20. Sequence analysis of PCR product from oligonucleotides containing a cis-syn ThymineThymine dimer. Black, green, red, and blue represent guanine, adenine, thymine, and cytosine bases
respectively. Amplification of the A) Dimer CONTROL oligonucleotide resulted in PCR products
containing the appropriate thymine substitutions (boxed). PCR products from amplification of the B) TT
Dimer1 template resulted in multiple sequences; guanine is present in the sense strand at the site of
modification suggesting dCMP was predominately incorporated across from the dimer; multiple minority
peaks were observed but could not be distinguished. Sites of DNA modification are designated (M) in the
sequence header.
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Table 4.21. Summary of PCR derived mutation as a result of lesion bypass.

Sample

Majority Nucleotidea

Minority Nucleotideb

Oxo CONTROL

no modification

no modification

OxodG1 (48)

dCMP

dAMP

OxodG2A (48/61)

dCMP

dAMP

OxodG3A (48/53/61)

dCMP

dAMP; possible n-1c

OxodG2T (47/48)

dCMP

n-1c; dAMP

OxodG3T (46-48)

NA

NA

OxodG4T (45-48)

NA

NA

OxodG6 (45-48/59/60)

NA

NA

OxodA1 (49)

dTMP

n-1c

Abasic (49)

possible dCMP

possible n-1c, possible n+1

Dimer CONTROLd

no modification

no modification

TT Dimer1

dCMP

possible n-1c, possible n+1

a- Predominant nucleotide incorporated opposite site of DNA base modification.
b- Secondary sequences created, in addition to the majority sequence, during the PCR; listed by order of
observed fluorescent intensity.
c- Observed frame-shifting originated at site of modification.
d- To create Dimer CONTROL, with respect to the Oxo CONTROL sequence and the 3’ terminus, thymine
base substitutions were made at positions 49, 50, and 59 (Table 3.1).

4.2.3. Restorase DNA polymerase misincorporates nucleotides opposite base lesions

Four 90-mer oligonucleotides were amplified using the Restorase DNA
polymerase system (Sigma). To determine base incorporation opposite the modifications,
PCR products were sequenced as described above (section 3.3.3.). PCR products from
all templates tested contained the sequencing primer binding site which suggested lesion
bypass and full-template amplification (summarized in Table 4.22).

Sequences of

products from the Oxo CONTROL oligonucleotide template were as expected (Figure
4.21A; Table 3.1). Restorase bypass of 8-oxodG modifications (OxodG2A) produced
multiple sequences, the majority of which mimicked the control; however, some products
contained guanine to thymine transversions suggesting dAMP incorporation opposite the
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site of modification (Figure 4.21B). Templates containing 8-oxodA resulted both in
expected and PCR products with n-1 deletions originating at the site of modification
(Figure 4.21C). The majority of products produced from abasic site bypass by Restorase
followed the “A-rule”, with dAMP being the predominate nucleotide incorporated
opposite the empty abasic site (Figure 4.21D; (73)). In addition to dAMP incorporation,
n-1 deletions were present, originating at the abasic site, in some PCR products (Figure
4.21D).

105

A

B

C

D

Figure 4.21. Sequence analysis of PCR product from modified oligonucleotides amplified by
Restorase DNA polymerase. Black, green, red, and blue represent guanine, adenine, thymine, and
cytosine bases respectively. Amplification of 90-mer A) Oxo CONTROL oligonucleotides using Restorase
DNA polymerase resulted in the expected Anderson sequence (156). B) The majority of nucleotide
insertions opposite 8-oxodG modifications (OxodG2A) were dCMPs; some dAMP insertion was observed
at one of the modified sites (solid down arrow). C) OxodA1 oligonucleotide template produced products
with dTMP incorporations (majority) and n-1 deletions (minority; designated with dashed down arrows).
D) Abasic templates resulted in multiple PCR products; dAMP incorporation (majority) and n-1 deletions
(minority; designated with dashed down arrows) were observed. Sites of DNA modification are designated
(M) in the sequence header
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Table 4.22. Restorase lesion bypass productsa.

Sample

Majority Nucleotide

Minority Nucleotide

Oxo CONTROL

no modification

no modification

OxodG2A (48/61)

dCMP

dAMPb

OxodA1 (49)

dTMP

n-1

Abasic (49)

dAMP

n-1

a- Sequence descriptions were as described in Table 4.18.
b- dAMP incorporation was only detected above background fluorescence opposite the 8-oxodG
modification at position 61 and not the modification at position 48.
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CHAPTER V
Summary and Conclusions
5.1. Quantification of DNA Damage
Implicating DNA damage as a preliminary step in carcinogenesis and aging
emphasizes a need for clinical assays to screen for aberrant amounts of damage to cellular
DNA. Current QPCR methods are the most sensitive of the polymerase stop based
assays but require long template amplification (greater than 10 kb; (5)) and, in some
cases, the use of hazardous radioisotopes. To alleviate these requirements, real-time PCR
mathematics and protocols were adapted to quantify damage to DNA. In addition to
redefining changes in CT values as degrees of damage rather than differences in input
template, data indicated that different types and amounts of DNA base modification
impact the rate of the PCR to different degrees. The observation that lesions did not
terminally block Taq polymerase progression lead to the discovery of lesion induced PCR
mutagenesis.

5.1.1. Lesion bypass

When present in synthetic templates, 8-oxodG, 8-oxodA, and abasic sites are
known to retard but not absolutely block extension by the Klenow fragment of E. coli
DNA polymerase I (2, 18, 51, 68, 73) and Taq DNA polymerase is able to slowly bypass
cis-syn thymidine dimers (87). These properties are consistent with the observation that
replication of some damaged templates is impeded, but not absolutely blocked, during
early rounds of the PCR (Figures 4.6-4.8).
Lesion bypass during the PCR results in the creation of unmodified amplicons
that mimic the reaction kinetics of the control templates masking any influence of
modifications on reaction efficiency at detectable fluorescent levels (Figure 5.1).
Creation of novel mathematical treatments to define differences between PCRs with
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equal template amounts as differences in the rate of reaction efficiencies from templates
with DNA modification were necessary to characterize this apparent lag in early

PCR Product

exponential amplification (Figure 5.2).

Oxo CONTROL

Modified Template

Cycle Number
Figure 5.1. Observed PCR curves of modified and unmodified templates. Templates containing DNA
base modifications hinder but do not halt the PCR. PCR derived unmodified amplicons are present in each
subsequent cycle and produce reaction curves, at detectable fluorescence levels, that mimicked those of
unmodified control templates.
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PCR Product

Oxo CONTROL
Modified Template

Cycle Number
Figure 5.2. DNA base lesions create a delay in early exponential phase. Templates containing DNA
base modifications decrease the rate of the PCR. This decreased rate is observed as a rightward shift in
amplification curves prior to detectable amplification.

5.1.1.1. Rate of lesion bypass: the RTC efficiency method

The RTC method was designed to explain differences in PCR curves resulting
from inherent input template quality while holding input template quantity constant
(151). In early real-time PCR cycles, replication of full-length modified oligonucleotides
gave rise to unmodified PCR products which were exponentially amplified in subsequent
cycles.

Even though the amplification curves of unmodified and some modified

templates had similar exponential phases (Figure 5.1), rightward shifts in the
amplification curves of templates with single 8-oxodA, abasic site, TT dimer, with three
separated 8-oxodG, or with any number of tandem 8-oxodG modifications were observed
(Figures 4.6-4.8). This shift stemmed from a prolonged lag in early exponential phase
(Figure 5.2) that could be described as a difference in CT values and translated into RTC
efficiencies (Tables 4.3-4.5). Although a single 8-oxodG base had no detectable effect on
RTC efficiency, the presence of a single 8-oxodA, abasic site, and TT dimer
modifications dramatically reduced RTC efficiencies by 81.2%, 98.5%, and 99.2%
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respectively. Two tandem 8-oxodG bases reduced RTC efficiency by 98.5%. Assuming
that the reaction efficiencies from the ICR and full-length amplifications are identical and
assuming that these are interchangeable between templates, RTC efficiency is an
appropriate method to characterize large differences in the rate of the PCR resulting from
lesion bypass (Tables 4.3-4.5).

5.1.1.2. Rate of lesion bypass: the MME method

The mean modified efficiency method builds on the RTC method for quantifying
aggregate damage to DNA template using real-time PCR. By calculating the reaction
efficiencies for the ICR and full-length amplifications, as well as the amount of
fluorescence generated by each input template, and incorporating these into the equation
14, significant differences in MMEs were observed between the Oxo CONTROL and

both the OxodG1 and OxodG2A templates (statistically significant at p < 0.05; Table
4.9). These observations suggest the MME calculations are appropriate to characterize
small differences in the rate of lesion bypass during the PCR, not detectable using the
RTC method.

5.1.1.3. Different lesions influence PCRs to different degrees

DNA base lesions cause extended lags in exponential amplification during the
PCR. These lags result in rightward shift in real-time PCR curves and translated into
differences in RTC (Tables 4.3-4.5) and MME (Tables 4.8-4.10). Contrary to current
QPCR assumptions that thermostable polymerase progression is blocked by single
lesions, observations presented here indicated different lesions impact the PCR to
different degrees (Figure 5.3).
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0.8

Oxo CONTROL
.. GGG AAG CAG ATT TGG GTA..

.. GGX AAG CAG ATT TGG GTA..

OxodA1 (49)
.. GGG YAG CAG ATT TGG GTA..

Mean Modified Efficiency

OxodG1 (48)

0.7
0.6
0.5
0.4
0.3
0.2
0.1

Abasic (49)
.. GGG ZAG CAG ATT TGG GTA..

0

Oxo
OxodG1
CONTROL

OxodA1 Abasic

Figure 5.3. Different base modifications influence the PCR to different degrees. When compared to
sequence matched controls, mean modified efficiencies of templates containing single 8-oxodG (X), 8oxodA (Y), and abasic site (Z) modifications were reduced. These reductions in MME were base lesion
specific.

The observation that single 8-oxodA lesions decreased amplification efficiency by
82% when compared with 8-oxodG was unexpected and not easily explained. These base
modifications both contain additional hydroxyl groups at the 8th position on their
respective purine rings (8-oxodG formation reviewed in above; Figure 2.2).

Both

modifications impact backbone dynamics of short oligonucleotides (157) but neither
severely impedes the progression of Klenow (18, 68). Initial reports diagramming 8oxodA bypass by Klenow indicate very low chain termination opposite 8-oxodA (67).
Studies also show that, in the presence of excess polymerase, the insertion and extension
of dTMP opposite the 8-oxodA lesion far exceed that of any other dNTP (68). Given that
dTMP is exclusively incorporated opposite the 8-oxodA modification, one possible
explanation of the observed drop in RTC and MMEs from 8-oxodA containing templates
is the presence of dUTP (rather than dTTP) in the experimental dNTP mixture; a measure
used to decrease PCR carryover contamination. The insertion kinetics of an incoming
dUMP opposite 8-oxodA has not been characterized and it is certainly possible that this
112

could impact the PCR.

The increase in observed RTC efficiencies from 8-oxodA

templates in the Restorase reactions strengthens this hypothesis.

These reactions

contained dTTP and corroborated earlier reports of 8-oxodA bypass by Taq (Figures 4.4,
4.13; (67)). Results must be viewed with caution because the possibility of lesion repair
exists in reactions with Restorase; however, the likelihood of this impacting reactions
with 8-oxodA is decreased due to repair selectively (165), the use of ssDNA (Restorase
repair works on duplex DNA (167)), and the short incubation times (less than 5 min) at
low temperatures (4o C; (165)).
A tetrahydrofuran analog (synthetic abasic site) creates a more formidable block
to Klenow progression but full-length extension products are eventually generated (73).
Smith et al. (1998) report that both Klenow and Taq are able to bypass cis-syn dimers
slowly; with both polymerases stopped one nucleotide prior to and directly opposite the
3’-T and with Taq synthesis also stopped opposite the 5’-T (87). Observations presented
here are in full agreement with these results; PCRs from templates with abasic sites and
TT dimers are slowed dramatically but not stopped completely, which resulted in
significantly lower RTC and MMEs (Tables 4.3, 4.5 and 4.8, 4.10 respectively).

5.1.1.4. The position of 8-oxodG lesions relative to each other impacts the PCR

The presence of the 8-oxo group can cause pronounced changes in base
interactions and changes in phospho-deoxyribose backbone (157). These alterations in
template secondary structure could prevent Taq DNA polymerase advancement resulting
in the observed reduction in RTC and MMEs. Increased numbers of 8-oxodGs
systematically reduced RTC and MMEs; coupled with observations that placing 8oxodGs adjacent to one another (OxodG2T; OxodG3T; OxodG4T; OxodG6) enhanced
the reduction (Figure 5.4), an argument that the position of base modifications on a DNA
template has a much greater influence in reducing template amplification than does the
number of 8-oxodG modifications can be made and that these reductions may, in part, be
attributed to altered oligonucleotide backbone structure.
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0.8

Oxo CONTROL
.. GGG AAG CAG ATT TGG GTA..
Mean Modified Efficiency

OxodG2A (48/61)
.. GGX AAG CAG ATT TGG XTA..

0.7
0.6
0.5
0.4
0.3
0.2

OxodG2T (47/48)
.. GXX AAG CAG ATT TGG GTA..

0.1
0

Oxo
OxodG2A OxodG2T
CONTROL

Figure 5.4. The positioning of multiple 8-oxodGs relative to one another significantly alters modified
reaction efficiency. Placing two modifications adjacent one another results in a 96% decrease in modified
amplification efficiency when compared to the MMEs from templates with two 8-oxodGs separated by 13
bases. Sites containing modified 8-oxodG bases are designated by (X).

The basis for QPCR methods of DNA damage detection is that the PCR is
blocked by the presence of certain lesions in the DNA template which results in a
decrease in amplification product (5, 8-11). These methods assume that each lesion
blocks polymerase advancement to the same degree and that there are no positional
effects (e.g. that two separate lesions would have the same effect as two tandem lesions).
Observations that the type and position of base damage strongly influenced the PCR to
differing degrees, suggest that some QPCR methods may underestimate or overestimate
the amount of damage.

5.1.2. Calculation of lesion abundance

Current QPCR DNA damage assays rely on endpoint analysis and, in some
instances, the incorporation of radiolabeled nucleotides in order to quantify PCR product
from damaged or undamaged templates (5, 8-11). In addition, these methods require the
independent establishment of exponential phase amplification for each DNA target (5, 8114

11). Adaptation of real-time PCR technology to DNA damage detection methods have
allowed for rate-based determination of the extent of damage and obviated the need for
radiolabeled nucleotides (151).
Most real-time PCR protocols require a short target DNA, usually less than one
hundred fifty base pairs to insure high amplification efficiency. However, in order to
achieve detection of biologically relevant levels of damage and estimate the sensitivity of
the detection method, protocols for the real-time amplification of larger (1000-10,000 bp)
target must be developed. In addition, development of formulae which calculate the
probability of encountering a damaged base in cellular DNA containing both damaged
and non-damaged template from changes in threshold cycle vales was required.
To validate real-time PCR for detection of biologically relevant levels of UV
induced photoproducts in cellular DNA, mtDNA fragments ranging from 600 bp to 2.25
kb (Amplicons 2-5; Figure 3.4) were amplified using the ABI 7000 sequence detection
system from total cellular DNA stocks which had been previously determined to contain
0 L, 0.5 L, and 1.0 L per 10 kb by conventional QPCR methods (11). Significant
differences in cycle threshold CT values were observed and, in combination with
equation 26, translated into lesion frequencies (Table 4.18). Significant levels of damage,
ranging from 1 to 4 lesions per 10 kb, were consistently detected in amplicon sizes
greater than 1.5 kb (Table 4.18).
Despite maintaining trends between both sample populations, real-time based
polymerase stop assays estimated damage to be 1.9 to 4.8-fold higher than QPCR assays.
This increase in frequency could be explained by differences in (1) amplification targets
or (2) PCR protocols.
Previous studies comparing oxidative damage to nuclear and mitochondrial DNA
suggest that mtDNA has a two to three fold higher lesion frequency than nuclear targets
in the same sample (5, 11). It is reasonable to assume that UV damage would present
with similar patterns and therefore the observed differences in lesion frequency would be
expected. However, Kalinowski et al. (1992) see only marginal, although elevated,
differences between lesion frequencies of nDNA and mtDNA from UV irradiated sample
material (approximately 1.5-fold more in mtDNA (7)). In general, such discrepancies
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may be caused by a difference in AT content. However, a review of the targets used in
this study yielded no appreciable difference in sequence content. Therefore, at least in
this case, AT content was not a likely cause in observed differences in lesion frequency
(data not shown).
Shielding by nuclear chromatin may afford protection to nDNA, a mechanism not
found in mitochondria and therefore can not be ruled out as a possible reason for lesion
differences in mitochondrial and nuclear DNA. In addition, NER mechanisms which
remove bulky adducts from DNA do not exist in the mitochondria and could inflate the
proportion of mitochondrial versus nuclear lesions should damaged cells have time to
initiate repair processes (9). Approximately 10% of UV induced blocking lesions are
repaired after 4 hrs (7); making it highly unlikely that appreciable repair occurred
between exposure and freezing in this current study.
QPCR employs rTth DNA polymerase XL and a protocol optimized to amplify
long fragments of DNA.

The real-time PCR assay described here uses Taq DNA

polymerase and was adapted from protocols optimized to amplify short fragments (less
than 150 bp). Despite a similarity in polymerases, differences in incorporation/extension
kinetics past DNA modifications would result in changes in observed lesion frequencies.
While certainly possible, the likelihood that these differences would impact lesion bypass
to a degree significant enough to alter lesion frequencies is remote (as inferred by lesion
bypass simulations; Table 4.20).

QPCR measures lesion frequency based on the

amplification of longer DNA targets (5, 11). It is possible that UV photoproducts impact
the PCRs to a lesser degree in longer DNA target lengths and would, therefore, increase
the observed lesion frequencies in shorter templates.
Even with observed differences in lesion frequency, these data implied that realtime PCR protocols could be adapted to estimate relevant amounts of UV damage in
cellular DNA and may provide greater sensitivity than conventional QPCR protocols.

5.1.3. Matched controls are required for real-time PCR quantification

In order to prepare an appropriate control template for the TT Dimer1
oligonucleotide, several thymidine substitutions were made in the Oxo CONTROL
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sequence (Table 3.1). The RTC and MMEs from this Dimer CONTROL (1.03 and 1.28;
Tables 4.5, 4.10) were greater than those of Oxo CONTROL (0.544 and .776; Tables 4.3,
4.8). Theoretically, these values should have equaled 1.0; the differences represented
shifts in the full-length amplification curves when compared with curves from the ICRs
(Figure 4.6). Observed differences in control RTC and MMEs can be explained by a
reduction in the stability of secondary structure in the Dimer CONTROL template which
resulted in improved Taq progression (Figures 4.9, 4.10). These observations emphasize
the need for matched controls in the RTC/MME methods and, for that matter, any realtime PCR protocol.

5.1.4. PCR efficiency during early amplification impacts real-time calculations

Nogva et al. (2004) present evidence that products produced in early rounds of
amplification by the PCR form secondary structures that alter their respective replication
efficiencies and impact real-time PCR based transcript abundance calculations (Figure
2.8; (145)). The work presented here is in agreement with these findings (Figures 4.9,
4.10); adding that DNA base lesions impact early rounds of the PCR and influence
current real-time PCR mathematics (Tables 4.1, 4.2). Due to the decreased probability of
encountering a damaged site in short targets (used in most real-time PCR assays;
presented in lesion frequency results section 4.1.2.1.), attempts to correlate DNA amounts
determined from short template amplification to those of larger targets should be done
with great caution. An example of this would be the use of real-time PCR to determine
DNA amounts in forensic science where the environmental assault on sample material is
great; the amplification of 50 bp (real-time PCR target) may not translate into amplifiable
DNA at 400 bp (largest target loci). In these cases, it would be more appropriate to
define results obtained as amplifiable template at a particular target length than it would
be to report template abundance from real-time data.
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5.2. Lesion Induced PCR Mutation
5.2.1. PCR derived mutation as a consequence of lesion bypass

The generation of full-length products in PCRs with 8-oxodG, 8-oxodA, abasic,
and TT dimer lesion containing oligonucleotide templates suggested that Taq DNA
polymerase was not completely blocked by these base modifications. These observations
are in accordance with lesion bypass studies using DNA polymerase I (2, 18, 51, 68, 73)
and indicate the assumption that lesions block thermostable polymerase progression
requires revision (5). Given that these lesions do not completely block Taq, the degree to
which the fidelity of the PCRs was impacted was characterized.
From previous work done by others, in addition to influencing the rates of proper
nucleotide insertion and extension, the capability to insert mismatched bases by many
DNA polymerases is increased in the presence of base lesions (2, 18, 51, 68, 73). For
example, Shibutani et al. (1991) report that dAMP is introduced opposite 8-oxodG and
readily extended by both the Klenow fragment and intact DNA polymerase I; therefore,
8-oxodG is considered pre-mutagenic (17). Sequence data from PCR products obtained
from reactions with 8-oxodG templates contained a mixture of dG and dT at the sites of
modification suggesting that both dCMP and dAMP were incorporated by Taq DNA
polymerase and, therefore, that the 8-oxodG base lesion was pre-mutagenic in the PCRs
(Figure 4.18).
8-oxodA, on the other hand, is not mutagenic in the presence of all four dNTP
promoting the insertion and extension of dTMP by DNA pol I opposite the site of
damage (68). The authors point out, however, that if the concentration of the polymerase
is reduced 100-fold, translesional synthesis past 8-oxodA by Klenow is retarded one base
before and directly opposite the lesion (68). Guschlebauer et al. (1991) observe that, in
the presence of all four dNTPs, Taq DNA Polymerase (1 U of enzyme) directs dTMP
incorporation exclusively (67). In addition to the expected dTMP, n-1 deletions were
observed in PCRs with 8-oxodA originating at the site of modification (Figure 4.19A).
These findings were surprising as they aren’t consistent with other reports of Taq
polymerase bypass of this lesion (67). One possible explanation for this discrepancy is
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that the amount of enzyme used in each study differed; while the amount of enzyme in
the Applied Biosystems master mix used within is proprietary, the number of units of
enzyme per reaction were estimated to be half of that used in the Guschlebauer et al.
(1991) experiments (data not shown; (67)). Given, when in excess, Klenow is also not
hindered at the site of modification (68), it is reasonable to assume that an excess amount
of Taq would react in the same fashion and could explain why Guschlebauer and
colleagues observed no 8-oxodA impact on Taq polymerase progression. In addition, the
ABI master mix contains a dNTP mixture with dUTP; a measure used to decrease PCR
carryover contamination. The insertion kinetics of an incoming dUMP opposite 8-oxodA
has not been characterized and it is certainly possible that this could result in decreased
polymerase fidelity and the observed n-1 deletion. This argument is strengthened by the
apparent decrease in n-1 deletion products from the Restorase PCRs; containing dTTP
rather than dUTP (Figure 5.5).

A

B

Fig. 5.5. Mutations opposite 8-oxodA lesions are reduced with Restorase. Black, green, red, and blue
represent guanine, adenine, thymine, and cytosine bases respectively. The frequency of n-1 deletions
appears to decrease in reactions with the A) Restorase polymerase mixture and dTTP in comparison to B)
AmpiTaq Gold and dUMP.
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Smith et al. (1998) report that both Klenow and Taq are able to bypass cis-syn
dimers slowly (87). Data presented here are in agreement with these findings as the
presence of the primer binding site required for the cycle sequencing reactions suggested
that full-length products were generated.

dCMP was the most incorporated dNTP

opposite the modification and the lack of readable sequence post modification suggested
the presence of multiple frameshifting mutations; originating at the site of damage
(Figure 4.20B).
In reactions containing templates with single abasic sites, a stalling occurred
during early amplification (as suggested by the RTC and MME data) and the resulting
lesion bypass produced a mixture of n-1 deletions and n+1 insertions (Figure 4.19B).
While data suggested the tetrahydrofuran analog in this Taq polymerase model didn’t
follow the A-rule proposed by Grollman and colleagues, a mechanistic deletion similar to
that seen by Shibutani et al. (1997) with Klenow was observed (73). In this model,
authors hypothesize that sequences flanking the absent base can mispair during the period
in which the polymerase is stalled at the site of modification creating either insertions or
deletions (73).

5.3. Future Directions
Polymerase stop based assays used to determine lesion frequencies assume that
each DNA base lesion blocks polymerase advancement to the same degree and that there
are no positional effects (e.g. two separate lesions would have the same effect as two
tandem lesions). Since observations presented here implied that the type and position of
base damage strongly influenced the PCR (presented as differences in RTC and MME),
some polymerase stop assays may underestimate or overestimate the amount of DNA
damage (151).
The rate of lesion bypass can be estimated using RTC or MME.

These

measurements can be determined and, using equation 27, incorporated into lesion
frequency calculations (as presented as estimations in Table 4.20). In addition, novel
formulae, presented in Appendix E, model the PCRs of mixed templates and report both
lesion bypass rate and lesion frequency. Work to adapt lesion frequency measurements
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to include rate of lesion bypass will increase precision and accuracy of lesion abundance
measurements. However, instrument precision, in its current format, is insufficient to
permit these types of calculations but may occur in the future as technology advances
(Appendix E).
Real-time PCR based damage quantification methods presented here represent a
stepping stone for the implementation of polymerase stop based assays as clinical tools to
estimate DNA damage. Advancement of real-time PCR instrumentation and polymerase
stop based protocols could present alternatives to current clinical monitoring assays of
DNA intercalating drugs such as Cisplaten. In addition, screening aggregate levels of
DNA damage and/or rates of DNA repair in age and cancer related disorders by PCR
methods could become possible. Work to characterize the sensitivity limits of these
assays is the next step in determining applicability of real-time PCR damage
quantification methods in both research and clinical settings.
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APPENDIX A
PCR Primers
Primers were adapted from Levin et al. (1999), Ayala-Torres et al. (2000), or
created using ABI primer express software to amplify fragments of mtDNA from cellular
and synthetic samples (Table A.1; (10, 158)).

Table A.1. Oligonucleotide primer sequences.
Designationa
FWD#15912
REV#93
Oxo CONTROL
FWD#12-B
REV#16090
FWD#16138c
REV#16053
REV#16095
REV#14841
FWD#14620
FWD#14470
FWD#14148
FWD#13899
FWD#13188
FWD#12601
FWD#11760
FWD#14642
REV#14693

OLIGONUCLEOTIDE SEQUENCE
5’-CCAGTCTTGTAAACCGGAGATGA-3’
5’-TCGCAATGCTATCGCGTG-3’
See Table 3.1
5’-AGACCTGTGATCCATCGTGAT-3’
5’-TATTTCGTAATTACTGCCAGCC-3’
5’-CCCAAAGCTAAGATTCTAATTT-3’
5’-GGGTGAGTCAATACTTGGGT-3’
5’-CATGAAAGAACAGAGAATAGT-3’
5'-TTTCATCATGCGGAGATGTTGGATGG-3'
5’-CCCCACAAACCCCATTACTAAACCCA-3’
5'-TCCAAAGACAACCATCATTCC-3'
5'-CCTATTCCCCCGAGCAATCTCAATTAC-3'
5'-TTTCTCCAACATACTCGGATTC-3'
5'-CACTCTGTTCGCAGCAGTCTG-3'
5'-TTCATCCCTGTAGCATTGTTCG-3'
5’-ACGAACGCACTCACAGTCG-3’
5'-CCCACACTCAACAGAAACAAAGC-3'
5'-TGTAGTCCGTGCGAGAATAATGAT-3'

Functionb
751 bp template
751 bp template
Modified Oligo ligation
Modified Oligo ligation
Oligo ligation- ICR
90mer Oligo
90mer Oligo-Full
90mer Oligo- ICR
Amplicons 1-7
Amplicon 1
Amplicon 2
Amplicon 3
Amplicon 4
Amplicon 5
Amplicon 6
Amplicon 7
LX-ICR
LX-ICR

a- Numerical designation is based on Anderson mtDNA reference sequence (154).
b- To create Amplicons 1-7, forward PCR primers were coupled with REV#14841.
c- Also used in combination with FWD#12 to amplify full-length ligated Oligo templates.
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APPENDIX B
Amplicon Size Impacts Threshold Cycle Values
The real-time PCR assays presented here are based on the increase of excited
fluorescent dye corresponding to an increase in PCR product formation during
amplification. SYBR Green dye, used in these experiments, is an intercalating agent that
can be excited when associated with double stranded DNA. It is reasonable to assume
that larger amplicon target sizes will permit more dye incorporation.
To determine if increased dye incorporation translated into observed differences
in CT values, untreated cellular DNA stocks were amplified using LX-ICR primers
(Appendix A) and then diluted to attain CT values of 19.5 (based on direct 2-∆CT
comparison methods (141)). Diluted samples were then amplified using the primer
walking strategy described above (Figures 3.4, 4.15) and CT values obtained.

As

amplicon sizes increased from 51 bp to 693 bp, CT values dropped from 19.61 to 17.83
(Table B.1). Further increases in amplicon size resulted in observed increases in CT
values (Table B.1). Given that 2-∆CT comparison mathematics assumes that efficiency of
the reaction is equal between templates (141), the observations above suggested that
increased dye incorporation endured by larger amplicons decreased observed CT values
until the efficiency of large fragment amplification became low enough to ultimately
mask any dye influences.

Table C.1. Amplicon sizes and threshold cycle values.
Amplicon
CT
S. D. CT Efficiency
19.61
0.291
1.000a
51 bp
18.21
0.028
0.953
221 bp
17.83
0.100
0.891
693 bp
18.49
0.134
0.849
942 bp
19.50
0.111
0.751
1654 bp
21.05
0.059
0.692
2241 bp
a- Estimate of efficiency based on short template assumptions (141).
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APPENDIX C
Dissociation Curves and PCR Product Gels from Long Extension PCRs
Dissociation profiles can be used to determine homogeneity of PCR products and
may suggest the presence of non-specific product formation during the PCRs (Figure
4.16). To generate these profiles, temperatures are increased to denature duplex DNA
and therefore decrease the amount of SYBR incorporation and subsequent fluorescent
intensity. With longer amplicon targets, the likelihood of encountering regions within an
amplicon that have different denaturation kinetics increases.
To determine if increasing amplicon size impacted observed dissociation profiles,
the primer walking strategy described above was again used (Figures 3.4, 4.15); by
holding the reverse primer constant at all amplicon sizes, larger targets effectively
contain the smaller ones (for example, the 693 bp amplicon is contained in the 2.25 kb
amplicon; Figure 4.15). Five different targets were amplified, ranging from 221 bp to
2.25 kb, and the products were separated by agarose gel electrophoresis (Figure C.1).
Single bands of expected sizes were observed in all cases suggesting unique product
formation.

2241 bp
1654 bp
942 bp
693 bp
221 bp
1

2

3

4

5

Figure C.1. Product gel of long templates PCRs. PCR products ranging from 221 bp to 2.25 kb were
separated by agarose gel electrophoresis. The appearance of single bands suggested that unique products
were generated by each primer set. Lanes 1-5 represent reaction products from Amplicons 1, 3, 4, 5, and 6,
respectively.

Dissociation profiles for each sized amplicon were generated (Figure C.2). A unique
peak with an approximate melting temperature of 75o C was observed in the 221 bp

138

products. When product size was increased to 693 bp, two peaks with equal amplitude
could be distinguished. As product sizes increased from 900 to 2.25 kb the two peaks
observed in the 693 bp profiles existed but the amplitude of the first peak decreased as
product sizes increased. These observations, coupled with the unique bands on the PCR
product gel (Figure C.1), suggested that two distinct melting domains existed in the PCR
products larger than 693 bp; the impact of the first melting domain became less
influential on product denaturation as amplicon size increased.

0.8
0.7
0.6

Derivative

0.5
0.4
0.3
0.2
0.1

70

75

80

85

80

Temperature
Figure C.2. Dissociation profiles of long PCR products. Melting curves of PCR products ranging from
221 bp to 2.25 kb were created by incrementally increasing temperature. Multiple peaks were present in
dissociation profiles as PCR product size increased. The amplitude of the peaks shifted in larger products.
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APPENDIX D
Simulated Lesion Bypass and Lesion Frequency Calculations
In developing equation 26 above (section 3.4.4.), the assumption was made that
damaged input templates did not contribute to the reaction (11). It has been demonstrated
that, for DNA damaged by UV radiation (specifically TT dimers), that such templates do
contribute to the reaction but at a very low efficiency (of the order of 1%; (151)). In order
to confirm that this does not invalidate the results presented in section 4.1.2.1., an
additional mathematical model was developed which accounts for damaged templates
participating in the reaction but at efficiencies different to the undamaged templates. This
model was used to compute the lesion frequency over a range of simulated lesion bypass
efficiencies and demonstrated that the assumption did not significantly affect the
precision of the method (Table 4.20).
As before, let p be the proportion of damaged bases in the DNA (lesion
frequency), x0 be the number of input templates, xn the total number of molecules present
after n cycles of the PCR, and N be the number of base pairs in the target. Additionally,
let yn be the number of undamaged molecules present after n cycles of the reaction, and P
be the proportion of input templates that are undamaged creating
P = (1 − p ) N ,
xn = y n + (1 − P ) x0 , and
y 0 = Px0 .

Suppose now that in each cycle of the reaction, undamaged templates replicate with
efficiency EU, and damaged templates produce undamaged templates with efficiency ED.
Since the number of damaged templates is fixed at (1 − P ) x0 , the following equation
models each cycle of the reaction:
y n = (1 + EU ) y n −1 + E D (1 − P ) x0 .
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This equation has solution

y n = (1 + EU ) n y 0 +

(1 + EU ) n − 1
E D (1 − P ) x0 , or
EU

yn = (1 + EU ) n Px0 +

(1 + EU ) n − 1
ED (1 − P ) x0 . Finally
EU

(1 + EU ) n − 1
xn = (1 + EU ) Px0 +
E D (1 − P ) x0 + (1 − P ) x0
EU
n

is created.
For control input templates, P=1, and this reduces as usual to
xn = (1 + EU ) n x0 .

Again using the previous notation, where T denotes the common threshold value for both
damaged and undamaged templates, CU denotes the threshold cycle for undamaged
(control) templates, and CD denotes the threshold cycle for damaged templates, we have

T = (1 + EU ) CD Px0 +

(1 + EU ) CD − 1
E D (1 − P ) x0 + (1 − P ) x0
EU

and
T = (1 + EU ) CU x0

are produced.
Equating these two expressions for T and solving for P gives
P=

EU (1 + EU ) CU − E D (1 + EU ) CD + E D − EU
. Since P = (1 − p ) N ,
CD
CD
EU (1 + EU ) − E D (1 + EU ) + E D − EU

and
1/ N

⎛ E (1 + EU ) CU − E D (1 + EU ) CD + E D − EU ⎞
⎟⎟
p = 1 − ⎜⎜ U
CD
CD
⎝ EU (1 + EU ) − E D (1 + EU ) + E D − EU ⎠
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APPENDIX E
Simultaneous Calculation of Lesion Frequency and Rate of Lesion Bypass
In theory, it is possible to compare ∆CT values from reactions at two different
amplicon lengths and simultaneously calculate both lesion frequency and lesion bypass
rate.
By applying the equation described in the ABI RNaseP Specification Sheet (166),
the instrument specification to “distinguish between 5,000 and 10,000 genomic
equivalents with a 99.7% confidence level" can be converted to a CT Standard Deviation
of 0.16 (data not shown). At this time, these current limitations in instrumentation and
fluorescent detection do not provide the precision necessary to perform these damage
calculations. Below is a complete derivation of the formulae needed to simultaneously
calculate LBR and LF in the event instrument precision is increased.
Starting with equation 27 from Appendix D:

pN =

1 − EU (1 + EU ) CU − E D (1 + EU ) CD + E D − EU
,
EU (1 + EU ) CD − E D (1 + EU ) CD + E D − EU

which can be rearranged to give
1
− (1 + EU ) CU − 1 − (1 + EU ) CD p N + p N
E D EU
=
EU
(1 + EU ) CD − 1 − (1 + EU ) CD p N + p N

or

(

)

1
− (1 + EU ) CU − 1 − p N (1 + EU ) CD − 1
E D EU
=
.
EU
(1 + EU ) CD − 1 (1 − p N )

(

)

For convenience, let
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A=

1
− (1 + EU ) CU − 1 and
EU

B = (1 + EU ) CD − 1 , giving
ED
A − Bp N
=
.
EU B(1 − p N )

28

Making the assumption that lesion bypass occurs at the same relative rate for all template
length, in other words, assume that the quantity E D / EU is independent of template
length N.
Consider two PCRs in the experiment, using template lengths M and N respectively
(without loss of generality we may assume that M > N). Find EU, CU, and CD in the usual
manner (section 4.1.2.2.; Appendix E) for each and compute A and B from the formulae
above. Denote by AM and BM the values of A and B computed for the PCR using
templates of length M, and by AN and BN the values computed for the PCR using
templates of length N. By assumption:
E D AM − BM p M
=
and
EU
BM (1 − p M )
E D AN − BN p N
=
. Hence
EU
BN (1 − p N )
AN − BN p N
AM − BM p M
,
=
BN (1 − p N ) BM (1 − p M )

29

which is simplified to
( BN − AN ) BM p M − ( BM − AM ) B N p N + AN BM − AM BN = 0

30

Equation 29 can be solved for p; in general, the equation cannot be solved algebraically
(though it may be noted that if M=2N it can be reduced to a quadratic equation), so a
method for solving this numerically using Newton’s method is presented.
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First observe that there is a spurious solution at p=1 (this solution results from
multiplying both sides of equation 29 by (1-pN)(1-pM) to obtain equation 30). Note also
that the function
f ( p ) = ( BN − AN ) BM p M − ( BM − AM ) B N p N + AN BM − AM BN
has a single turning point at
⎛ N ( BM − AM ) BN
p* = ⎜⎜
⎝ M ( BN − AN ) BM

1

⎞ M −N
⎟⎟
.
⎠

It follows that there is exactly one more zero of f(p), corresponding to the solution to
equation (26) (the lesion frequency).
In order to find this solution, Newton’s method is employed. Choosing to start with the
value p0=1-2p*, which will be close to the desired solution. Newton’s method gives the
iteration
pn +1 = pn −

f ( pn )
( B − AN ) BM pnM − ( BM − AM ) BN pnN + AN BM − AM BN
= pn − N
.
f ' ( pn )
M ( BN − AN ) BM p M −1 − N ( BM − AM ) BN p N −1

This iteration can be repeated until convergence to any degree of precision is obtained:
typically it will converge to a precision of 2n digits after n iterations.
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